Michael S Okun

Michael S Okun, MD

Director, Norman Fixel Institute for Neurological Diseases

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 294-5400
Business Email: okun@neurology.ufl.edu

About Michael S Okun

My name is Michael Okun, MD, and I am a board-certified neurologist, movement disorders specialist, neuroscientist and author who practices with the philosophy that ‘the patient is the sun’ and should be at the center of all care decisions.

I co-founded and co-direct the internationally-renowned Norman Fixel Institute for Neurological Diseases with my neurosurgeon partner and friend, Kelly Foote, MD. Since 2006, I have served as both the Medical Director and most recently as the Medical Advisor for the Parkinson’s Foundation.

I completed my medical degree in 1996 from the University of Florida. Following my medical degree, I completed my internship in 1997 and neurology residency in 2000, both at the University of Florida (Go Gators!). I then completed my fellowship in movement disorders and surgery for movement disorders in 2002 at Emory University in Atlanta, Georgia.

I see patients for a variety of movement related neurological disorders including Parkinson’s disease, tremor Tourette syndrome, dystonia and more. As a care provider, I strive to translate physiological principles underpinning neurological disorders into real-world therapies to improve a patient’s life and wellbeing.

When I am not caring for patients, I conduct human research including clinical trials and the cognitive, behavioral and mood effects of deep brain stimulation (DBS) and neuromodulation. My research projects have included the application of DBS and neuromodulation therapies for the treatment of Parkinson’s disease, Tourette syndrome and tic disorders, dystonia, essential tremor and obsessive-compulsive disorder. My research has received support from the National Institutes of Health, the Smallwood Foundation, the Tourette Association of America, the Parkinson’s Alliance, the Parkinson’s Foundation and the Michael J. Fox Foundation.

As a doctor, I am passionate about the importance of arts in medicine. In 1995, I authored my first book of poetry, Lessons From the Bedside. Since my first book, I have authored 14 books related to living a full life with neurological disorders including Parkinson’s Treatment: 10 Secrets to a Happier Life and Ending Parkinson’s Disease. I have also published more than 600 papers and review articles on Parkinson’s and other movement disorders.

In my free time, I enjoy spending time with friends and family, podcasts, reading history, going on walks with our family dog and watching baseball.

Additional Positions:
Director
2019 – Current · Norman Fixel Institute for Neurological Diseases
Related Links:

Accomplishments

Clinical Science Researcher of the Year Award
2021 · University of Florida College of Medicine
Presidential Award for Translational Research
2018 · American Society for Experimental Neurotherapeutics
White House Champion of Change
2015 · President Obama and Administration

Teaching Profile

Courses Taught
2013-2018
MDT7800 Elect Top/Neurology
2018
EEL7980 Research for Doctoral Dissertation
2018
GMS7980 Research for Doctoral Dissertation
2013
CLP7980 Research for Doctoral Dissertation
2010-2013
MEL7930 Elect Top/Neurology
2021
MDC7800 Neurology Clerkship

Clinical Profile

Specialties
  • Neurology
Areas of Interest
  • Basal ganglia dysfunction
  • Chronic motor or vocal tic disorder
  • Deep brain stimulation
  • Dystonia
  • Essential tremor
  • Obsessive-compulsive disorder
  • Progressive supranuclear palsy
  • Tourette Syndrome and tic disorders
  • Tremor disorders

Research Profile

Areas of Interest
  • Alzheimer’s Disease
  • Deep brain stimulation
  • Depression
  • Dystonia
  • ECT Refractory Depression
  • Medication Refractory Obsessive Compulsive Disorder
  • Multiple Sclerosis Tremor
  • Multiple System Atrophy (MSA)
  • Parkinson’s disease
  • Progressive Supranuclear Palsy (PSP)
  • Surgical Treatments for Movement Disorders
  • Surgical Treatments for Neuro-psychiatric Disorders
  • Tourette Syndrome
Open Researcher and Contributor ID (ORCID)

0000-0002-6247-9358

Publications

2024
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society. 39(2):259-266 [DOI] 10.1002/mds.29683. [PMID] 38093469.
2024
Buna Joe “BJ” Wilder, MD (1929–2023)
Neurology. 102(8) [DOI] 10.1212/wnl.0000000000209404.
2024
Current perspectives on tractography-guided deep brain stimulation for the treatment of mood disorders.
Expert review of neurotherapeutics. 24(1):11-24 [DOI] 10.1080/14737175.2023.2289573. [PMID] 38037329.
2024
Current practices of burst vs. spaced physical therapy applied to Parkinson’s disease
Parkinsonism & Related Disorders. 120 [DOI] 10.1016/j.parkreldis.2024.106022.
2024
Deep brain stimulation for refractory major depressive disorder: a comprehensive review
Molecular Psychiatry. [DOI] 10.1038/s41380-023-02394-4.
2024
Management of essential tremor deep brain stimulation-induced side effects.
Frontiers in human neuroscience. 18 [DOI] 10.3389/fnhum.2024.1353150. [PMID] 38454907.
2024
Neuromodulation for the treatment of Prader-Willi syndrome – A systematic review.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 21(3) [DOI] 10.1016/j.neurot.2024.e00339. [PMID] 38430811.
2024
Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements.
Frontiers in human neuroscience. 18 [DOI] 10.3389/fnhum.2024.1320806. [PMID] 38450221.
2024
U.S. Tax Credits to Promote Practical Proactive Preventative Care for Parkinson’s Disease.
Journal of Parkinson's disease. 14(2):221-226 [DOI] 10.3233/JPD-240046. [PMID] 38457153.
2024
WarpDrive: Improving spatial normalization using manual refinements
Medical Image Analysis. 91 [DOI] 10.1016/j.media.2023.103041. [PMID] 38007978.
2023
A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson’s Disease.
Movement disorders clinical practice. 10(2):213-222 [DOI] 10.1002/mdc3.13603. [PMID] 36825053.
2023
Abandoning the Proteinopathy Paradigm in Parkinson Disease.
JAMA neurology. 80(2):123-124 [DOI] 10.1001/jamaneurol.2022.4193. [PMID] 36441542.
2023
Brain Recording Analysis and Visualization Online (BRAVO): An open-source visualization tool for deep brain stimulation data.
Brain stimulation. 16(3):793-797 [DOI] 10.1016/j.brs.2023.04.018. [PMID] 37100201.
2023
Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson’s Disease Psychosis.
Movement disorders clinical practice. 10(3):406-414 [DOI] 10.1002/mdc3.13652. [PMID] 36949798.
2023
Course of Impulse Control Disorder Symptoms in Parkinson’s Disease: Deep Brain Stimulation Versus Medications.
Movement disorders clinical practice. 10(6):903-913 [DOI] 10.1002/mdc3.13738. [PMID] 37332637.
2023
Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson’s disease and atypical parkinsonism
npj Parkinson's Disease. 9(1) [DOI] 10.1038/s41531-023-00521-0. [PMID] 37277372.
2023
Double blind, nonrandomized crossover study of active recharge biphasic deep brain stimulation for primary dystonia.
Parkinsonism & related disorders. 109 [DOI] 10.1016/j.parkreldis.2023.105328. [PMID] 36827951.
2023
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathy.
ACS chemical neuroscience. 14(2):235-245 [DOI] 10.1021/acschemneuro.2c00539. [PMID] 36571847.
2023
Focused Ultrasound Ablation in Parkinson’s Disease.
The New England journal of medicine. 388(19):1822-1823 [DOI] 10.1056/NEJMc2303750. [PMID] 37163637.
2023
Functional Movement Disorders and Deep Brain Stimulation: A Multi-Center Study.
Movement disorders clinical practice. 10(1):94-100 [DOI] 10.1002/mdc3.13609. [PMID] 36704077.
2023
Globus pallidus internus deep brain stimulation evokes resonant neural activity in Parkinson’s disease.
Brain communications. 5(2) [DOI] 10.1093/braincomms/fcad025. [PMID] 36895960.
2023
Hematoma-induced Twiddler-like phenomenon as a presentation of DBS hardware failure: Case report.
Frontiers in human neuroscience. 17 [DOI] 10.3389/fnhum.2023.1160237. [PMID] 37151898.
2023
Identification and Management of Persistent Stimulation-Induced Dyskinesia Associated with STN DBS: The See-Saw Dilemma
Tremor and Other Hyperkinetic Movements. 13(1) [DOI] 10.5334/tohm.780. [PMID] 37663531.
2023
Interactive mobile application for Parkinson’s disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial.
Parkinsonism & related disorders. 109 [DOI] 10.1016/j.parkreldis.2023.105346. [PMID] 36966051.
2023
Meta-analysis of Association between Newer Glucose-Lowering Drugs and Risk of Parkinson’s Disease.
Movement disorders clinical practice. 10(11):1659-1665 [DOI] 10.1002/mdc3.13893. [PMID] 37982117.
2023
Muhammad Ali and Young-Onset Idiopathic Parkinson Disease-The Missing Evidence.
JAMA neurology. 80(1):5-6 [DOI] 10.1001/jamaneurol.2022.3584. [PMID] 36279117.
2023
Neurosurgical lesioning for Tourette syndrome – Authors’ reply.
The Lancet. Neurology. 22(4):292-293 [DOI] 10.1016/S1474-4422(23)00079-0. [PMID] 36931795.
2023
Participant perceptions of changes in psychosocial domains following participation in an adaptive deep brain stimulation trial.
Brain stimulation. 16(4):990-998 [DOI] 10.1016/j.brs.2023.06.007. [PMID] 37330169.
2023
Practical proactive and preventative Parkinson’s disease strategies for management in the hospital setting.
Parkinsonism & related disorders. 113 [DOI] 10.1016/j.parkreldis.2023.105515. [PMID] 37453869.
2023
The current state, challenges, and future directions of deep brain stimulation for obsessive compulsive disorder.
Expert review of medical devices. 20(10):829-842 [DOI] 10.1080/17434440.2023.2252732. [PMID] 37642374.
2023
Tourette syndrome: clinical features, pathophysiology, and treatment.
The Lancet. Neurology. 22(2):147-158 [DOI] 10.1016/S1474-4422(22)00303-9. [PMID] 36354027.
2023
Type, Timing, Frequency, and Durability of Outcome of Physical Therapy for Parkinson Disease: A Systematic Review and Meta-Analysis.
JAMA network open. 6(7) [DOI] 10.1001/jamanetworkopen.2023.24860. [PMID] 37477916.
2023
Weight and survival after deep brain stimulation for Parkinson’s disease
Parkinsonism & Related Disorders. 115 [DOI] 10.1016/j.parkreldis.2023.105810. [PMID] 37660542.
2022
A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease.
Parkinsonism & related disorders. 97:57-62 [DOI] 10.1016/j.parkreldis.2022.02.021. [PMID] 35325665.
2022
Adjunctive Therapies in Parkinson Disease-Have We Made Meaningful Progress?
JAMA neurology. 79(2):119-120 [DOI] 10.1001/jamaneurol.2021.4140. [PMID] 34962569.
2022
Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy.
NeuroImage. Clinical. 34 [DOI] 10.1016/j.nicl.2022.103022. [PMID] 35489192.
2022
Clinical Reasoning: A Case of Acute Akinetic Mutism and Encephalopathy.
Neurology. 99(17):761-766 [DOI] 10.1212/WNL.0000000000201207. [PMID] 36008149.
2022
Cognitive subtypes in individuals with essential tremor seeking deep brain stimulation
The Clinical Neuropsychologist. 36(7):1705-1727 [DOI] 10.1080/13854046.2021.1882578. [PMID] 33567972.
2022
Connectomic analysis of unilateral dual-lead thalamic deep brain stimulation for treatment of multiple sclerosis tremor.
Brain communications. 4(2) [DOI] 10.1093/braincomms/fcac063. [PMID] 35368612.
2022
Connectomic imaging to predict and prevent cognitive decline after subthalamic DBS: next steps.
Brain : a journal of neurology. 145(4):1204-1206 [DOI] 10.1093/brain/awac101. [PMID] 35608893.
2022
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells.
NPJ Parkinson's disease. 8(1) [DOI] 10.1038/s41531-022-00333-8. [PMID] 35672374.
2022
Deep brain stimulation for obsessive–compulsive disorder: a crisis of access
Nature Medicine. 28(8):1529-1532 [DOI] 10.1038/s41591-022-01879-z.
2022
Diagnosis and Management of Functional Tic-Like Phenomena.
Journal of clinical medicine. 11(21) [DOI] 10.3390/jcm11216470. [PMID] 36362696.
2022
Differential contributions of depression, apathy, and anxiety to neuropsychological performance in Parkinson’s disease versus essential tremor
Journal of Clinical and Experimental Neuropsychology. 44(9):651-664 [DOI] 10.1080/13803395.2022.2157796. [PMID] 36600515.
2022
Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson’s Disease: A Placebo-Controlled Trial of Rasagiline.
Movement disorders : official journal of the Movement Disorder Society. 37(2):325-333 [DOI] 10.1002/mds.28838. [PMID] 34724257.
2022
Distinct Roles of the Human Subthalamic Nucleus and Dorsal Pallidum in Parkinson’s Disease Impulsivity.
Biological psychiatry. 91(4):370-379 [DOI] 10.1016/j.biopsych.2021.03.002. [PMID] 33993998.
2022
Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.912730. [PMID] 35721359.
2022
Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review
npj Parkinson's Disease. 8(1) [DOI] 10.1038/s41531-022-00339-2. [PMID] 35697709.
2022
Embedded Human Closed-Loop Deep Brain Stimulation for Tourette Syndrome: A Nonrandomized Controlled Trial.
JAMA neurology. 79(10):1064-1068 [DOI] 10.1001/jamaneurol.2022.2741. [PMID] 36094652.
2022
From pleasure to punding: Distinct patterns of anhedonia and impulsivity linked to motivational disturbances in Parkinson disease
Applied Neuropsychology: Adult. 1-6 [DOI] 10.1080/23279095.2022.2146506.
2022
Functional characterization of the biogenic amine transporters on human macrophages
JCI Insight. 7(4) [DOI] 10.1172/jci.insight.151892. [PMID] 35015729.
2022
Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder.
Lancet (London, England). 400(10348) [DOI] 10.1016/S0140-6736(22)01184-9. [PMID] 35871817.
2022
Laterality of motor symptom onset and facial expressivity in Parkinson disease using face digitization
Laterality. 27(1):57-70 [DOI] 10.1080/1357650x.2021.1946077.
2022
Online vs Face-to-Face Administration of Impulse Control Disorder Questionnaires in Parkinson Disease: Does Method Matter?
Neurology. Clinical practice. 12(5):e93-e97 [DOI] 10.1212/CPJ.0000000000200074. [PMID] 36380894.
2022
Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer’s disease
Nature Communications. 13(1) [DOI] 10.1038/s41467-022-34510-3. [PMID] 36517479.
2022
Past, Present, and Future of Deep Brain Stimulation: Hardware, Software, Imaging, Physiology and Novel Approaches.
Frontiers in neurology. 13 [DOI] 10.3389/fneur.2022.825178. [PMID] 35356461.
2022
Post-trial access in implanted neural device research: Device maintenance, abandonment, and cost.
Brain stimulation. 15(5):1029-1036 [DOI] 10.1016/j.brs.2022.07.051. [PMID] 35926784.
2022
Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.1084782. [PMID] 36819295.
2022
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.813387. [PMID] 35308605.
2022
Safety of deep brain stimulation in pregnancy: A comprehensive review.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.997552. [PMID] 36248692.
2022
Suppression of Axial Tremor by Deep Brain Stimulation in Patients with Essential Tremor: Effects on Gait and Balance Measures
Tremor and Other Hyperkinetic Movements. 12(1) [DOI] 10.5334/tohm.698. [PMID] 35854793.
2022
Temporally optimized patterned stimulation (TOPS®) as a therapy to personalize deep brain stimulation treatment of Parkinson’s disease.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.929509. [PMID] 36092643.
2022
The Human Tic Detector: An automatic approach to tic characterization using wearable sensors.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 134:102-110 [DOI] 10.1016/j.clinph.2021.10.017. [PMID] 34952803.
2022
The use of virtual reality to modify and personalize interior home features in Parkinson’s disease.
Experimental gerontology. 159 [DOI] 10.1016/j.exger.2022.111702. [PMID] 35038568.
2022
Therapeutic Advances in the Treatment of Holmes Tremor: Systematic Review.
Neuromodulation : journal of the International Neuromodulation Society. 25(6):796-803 [DOI] 10.1111/ner.13220. [PMID] 32578304.
2022
Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits.
JAMA neurology. 79(12):1219-1220 [DOI] 10.1001/jamaneurol.2022.2649. [PMID] 36094521.
2022
Why Some Individuals With Tourette Syndrome Experience Assault and Perpetrate Criminal Behavior.
JAMA neurology. 79(5):442-444 [DOI] 10.1001/jamaneurol.2021.5541. [PMID] 35311951.
2021
A novel local field potential-based functional approach for targeting the centromedian-parafascicular complex for deep brain stimulation.
NeuroImage. Clinical. 30 [DOI] 10.1016/j.nicl.2021.102644. [PMID] 33845353.
2021
Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes
npj Parkinson's Disease. 7(1) [DOI] 10.1038/s41531-021-00212-8. [PMID] 34341346.
2021
Bad Air and Parkinson Disease-The Fog May Be Lifting.
JAMA neurology. 78(7):793-795 [DOI] 10.1001/jamaneurol.2021.0863. [PMID] 33999105.
2021
Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette Syndrome.
Biological psychiatry. Cognitive neuroscience and neuroimaging. 6(10):961-972 [DOI] 10.1016/j.bpsc.2020.11.005. [PMID] 33536144.
2021
Brain structures and networks responsible for stimulation-induced memory flashbacks during forniceal deep brain stimulation for Alzheimer’s disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association. 17(5):777-787 [DOI] 10.1002/alz.12238. [PMID] 33480187.
2021
Case Report: GPi DBS for Non-parkinsonian Midline Tremor: A Normative Connectomic Comparison to a Failed Thalamic DBS.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.709552. [PMID] 34413730.
2021
Clinical Practice Patterns in Tic Disorders Among Movement Disorder Society Members.
Tremor and other hyperkinetic movements (New York, N.Y.). 11 [DOI] 10.5334/tohm.656. [PMID] 34754602.
2021
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease.
Journal of neurosurgery. 1-8 [DOI] 10.3171/2021.7.JNS21190. [PMID] 34798606.
2021
Closed-Loop Deep Brain Stimulation to Treat Medication-Refractory Freezing of Gait in Parkinson’s Disease.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.633655. [PMID] 33732122.
2021
Comparative connectivity correlates of dystonic and essential tremor deep brain stimulation.
Brain : a journal of neurology. 144(6):1774-1786 [DOI] 10.1093/brain/awab074. [PMID] 33889943.
2021
Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
Journal of managed care & specialty pharmacy. 27(6):785-790 [DOI] 10.18553/jmcp.2021.27.6.785. [PMID] 34057395.
2021
Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathway.
NeuroImage. Clinical. 32 [DOI] 10.1016/j.nicl.2021.102846. [PMID] 34624639.
2021
Corrigendum to: Comparative connectivity correlates of dystonic and essential tremor deep brain stimulation.
Brain : a journal of neurology. 144(8) [DOI] 10.1093/brain/awab192. [PMID] 34115824.
2021
Corrigendum: Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.765150. [PMID] 34658825.
2021
Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology
Expert Review of Medical Devices. 18(9):875-891 [DOI] 10.1080/17434440.2021.1962286.
2021
Detection of postural control in early Parkinson’s disease: Clinical testing vs. modulation of center of pressure
PLOS ONE. 16(1) [DOI] 10.1371/journal.pone.0245353. [PMID] 33434235.
2021
Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
Contemporary Clinical Trials Communications. 22 [DOI] 10.1016/j.conctc.2021.100785. [PMID] 34189335.
2021
Evolution of Globus Pallidus Targeting for Parkinson’s and Dystonia Deep Brain Stimulation: A 15-Year Experience.
Frontiers in neurology. 12 [DOI] 10.3389/fneur.2021.679918. [PMID] 34456844.
2021
From the grocery store shelves to the neurologist’s office: spinal cord effects of nitrous oxide
Neurocase. 27(4):382-383 [DOI] 10.1080/13554794.2021.1967405.
2021
Geospatial Analysis of Persons with Movement Disorders Living in Underserved Regions
Tremor and Other Hyperkinetic Movements. 11(1) [DOI] 10.5334/tohm.635. [PMID] 34513276.
2021
Global Variability in Deep Brain Stimulation Practices for Parkinson’s Disease.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.667035. [PMID] 33867961.
2021
Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary.
Neurology and therapy. 10(1):7-30 [DOI] 10.1007/s40120-020-00220-5. [PMID] 33140286.
2021
Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial.
JAMA neurology. 78(8):972-981 [DOI] 10.1001/jamaneurol.2021.1910. [PMID] 34180949.
2021
Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation.
Brain : a journal of neurology. 144(9):2837-2851 [DOI] 10.1093/brain/awab170. [PMID] 33905474.
2021
Palliative Care and Parkinson’s Disease: Time to Move Beyond Cancer.
Movement disorders : official journal of the Movement Disorder Society. 36(6):1325-1329 [DOI] 10.1002/mds.28556. [PMID] 33786871.
2021
Pallidal Connectivity Profiling of Stimulation-Induced Dyskinesia in Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society. 36(2):380-388 [DOI] 10.1002/mds.28324. [PMID] 33002233.
2021
Parkinson’s disease.
Lancet (London, England). 397(10291):2284-2303 [DOI] 10.1016/S0140-6736(21)00218-X. [PMID] 33848468.
2021
Patient, Caregiver, and Decliner Perspectives on Whether to Enroll in Adaptive Deep Brain Stimulation Research.
Frontiers in neuroscience. 15 [DOI] 10.3389/fnins.2021.734182. [PMID] 34690676.
2021
Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.644593. [PMID] 33953663.
2021
Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases.
JAMA neurology. 78(1):5-6 [DOI] 10.1001/jamaneurol.2020.4232. [PMID] 33165519.
2021
Response to: The need of reliable warning signs for dysphagia in Parkinson’s disease: an often-overlooked issue
Expert Review of Gastroenterology & Hepatology. 15(3):343-344 [DOI] 10.1080/17474124.2021.1842195.
2021
Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity Act.
Frontiers in psychiatry. 12 [DOI] 10.3389/fpsyt.2021.706181. [PMID] 34456762.
2021
Safety and Tolerability of Burst-Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.651168. [PMID] 33981207.
2021
Suppression and Rebound of Pallidal Beta Power: Observation Using a Chronic Sensing DBS Device.
Frontiers in human neuroscience. 15 [DOI] 10.3389/fnhum.2021.749567. [PMID] 34566612.
2021
Synaptic processes and immune-related pathways implicated in Tourette syndrome
Translational Psychiatry. 11(1) [DOI] 10.1038/s41398-020-01082-z. [PMID] 33462189.
2021
The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.
Neurology. 96(14):664-676 [DOI] 10.1212/WNL.0000000000011704. [PMID] 33593864.
2021
Time for a New 3-D Image for Globus Pallidus Internus Deep Brain Stimulation Targeting and Programming.
Journal of Parkinson's disease. 11(4):1881-1885 [DOI] 10.3233/JPD-212820. [PMID] 34420982.
2021
TNFα increases tyrosine hydroxylase expression in human monocytes
npj Parkinson's Disease. 7(1) [DOI] 10.1038/s41531-021-00201-x. [PMID] 34285243.
2021
Wearable sensor-driven responsive deep brain stimulation for essential tremor.
Brain stimulation. 14(6):1434-1443 [DOI] 10.1016/j.brs.2021.09.002. [PMID] 34547503.
2020
A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes.
Movement disorders : official journal of the Movement Disorder Society. 35(5):741-751 [DOI] 10.1002/mds.28045. [PMID] 32281147.
2020
A comprehensive review of the diagnosis and treatment of Parkinson’s disease dysphagia and aspiration
Expert Review of Gastroenterology & Hepatology. 14(6):411-424 [DOI] 10.1080/17474124.2020.1769475. [PMID] 32657208.
2020
A New Day: The Role of Telemedicine in Reshaping Care for Persons With Movement Disorders.
Movement disorders : official journal of the Movement Disorder Society. 35(11):1897-1902 [DOI] 10.1002/mds.28296. [PMID] 32870517.
2020
A novel approach to study markers of dopamine signaling in peripheral immune cells.
Journal of immunological methods. 476 [DOI] 10.1016/j.jim.2019.112686. [PMID] 31634479.
2020
A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia.
Journal of neurology. 267(5):1278-1290 [DOI] 10.1007/s00415-020-09703-9. [PMID] 31938862.
2020
An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00162. [PMID] 32733215.
2020
Brain Atrophy Following Deep Brain Stimulation: Management of a Moving Target.
Tremor and other hyperkinetic movements (New York, N.Y.). 10 [DOI] 10.5334/tohm.546. [PMID] 33133768.
2020
Care, Convenience, Comfort, Confidentiality, and Contagion: The 5 C’s that Will Shape the Future of Telemedicine.
Journal of Parkinson's disease. 10(3):893-897 [DOI] 10.3233/JPD-202109. [PMID] 32538870.
2020
Case Report: Globus Pallidus Internus (GPi) Deep Brain Stimulation Induced Keyboard Typing Dysfunction.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.583441. [PMID] 33240065.
2020
Choosing a Parkinson Disease Treatment.
JAMA. 323(14) [DOI] 10.1001/jama.2020.1224. [PMID] 32286645.
2020
Chronic embedded cortico-thalamic closed-loop deep brain stimulation for the treatment of essential tremor
Science Translational Medicine. 12(572) [DOI] 10.1126/scitranslmed.aay7680. [PMID] 33268512.
2020
Co-occurrence of apathy and impulse control disorders in Parkinson disease.
Neurology. 95(20):e2769-e2780 [DOI] 10.1212/WNL.0000000000010965. [PMID] 33004605.
2020
Coexistent Osteoarthritis and Parkinson’s Disease: Data from the Parkinson’s Foundation Outcomes Project.
Journal of Parkinson's disease. 10(4):1601-1610 [DOI] 10.3233/JPD-202170. [PMID] 32925102.
2020
Cognitive Outcomes for Essential Tremor Patients Selected for Thalamic Deep Brain Stimulation Surgery Through Interdisciplinary Evaluations.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.578348. [PMID] 33362489.
2020
Deep brain stimulation for Tourette’s syndrome.
Translational neurodegeneration. 9 [DOI] 10.1186/s40035-020-0183-7. [PMID] 31956406.
2020
Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes
Expert Review of Neurotherapeutics. 20(4):319-331 [DOI] 10.1080/14737175.2020.1737017. [PMID] 32116065.
2020
Deep brain stimulation lead removal in Tourette syndrome.
Parkinsonism & related disorders. 77:89-93 [DOI] 10.1016/j.parkreldis.2020.06.025. [PMID] 32712563.
2020
Deep Brain Stimulation Target Selection in Co-Morbid Essential Tremor and Parkinson’s Disease.
Tremor and other hyperkinetic movements (New York, N.Y.). 10 [DOI] 10.5334/tohm.62. [PMID] 32775031.
2020
Diagnosis and Treatment of Parkinson Disease: A Review.
JAMA. 323(6):548-560 [DOI] 10.1001/jama.2019.22360. [PMID] 32044947.
2020
Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis.
Journal of neurology, neurosurgery, and psychiatry. 91(4):426-433 [DOI] 10.1136/jnnp-2019-322169. [PMID] 32079672.
2020
Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit.
Journal of neurology, neurosurgery, and psychiatry. 91(5):533-539 [DOI] 10.1136/jnnp-2019-321973. [PMID] 32139653.
2020
Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit.
. 91(5)
2020
Dysarthria and Speech Intelligibility Following Parkinson’s Disease Globus Pallidus Internus Deep Brain Stimulation.
Journal of Parkinson's disease. 10(4):1493-1502 [DOI] 10.3233/JPD-202246. [PMID] 32955467.
2020
Effects of ventral intermediate nucleus deep brain stimulation across multiple effectors in essential tremor.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 131(1):167-176 [DOI] 10.1016/j.clinph.2019.10.019. [PMID] 31794958.
2020
Florida research open-source synchronization tool (FROST) for electrophysiology experiments.
Journal of neuroscience methods. 341 [DOI] 10.1016/j.jneumeth.2020.108800. [PMID] 32497676.
2020
Functional and Structural Connectivity Patterns Associated with Clinical Outcomes in Deep Brain Stimulation of the Globus Pallidus Internus for Generalized Dystonia
American Journal of Neuroradiology. 41(3):508-514 [DOI] 10.3174/ajnr.a6429.
2020
Gait characterization for patients with orthostatic tremor.
Parkinsonism & related disorders. 71:23-27 [DOI] 10.1016/j.parkreldis.2020.01.007. [PMID] 31981995.
2020
Implementation of a Novel Bluetooth Technology for Remote Deep Brain Stimulation Programming: The Pre- and Post-COVID-19 Beijing Experience.
Movement disorders : official journal of the Movement Disorder Society. 35(6):909-910 [DOI] 10.1002/mds.28098. [PMID] 32478886.
2020
Integrated and patient-centred management of Parkinson’s disease: a network model for reshaping chronic neurological care.
The Lancet. Neurology. 19(7):623-634 [DOI] 10.1016/S1474-4422(20)30064-8. [PMID] 32464101.
2020
Lead Repositioning Guided by Both Physiology and Atlas Based Targeting in Tourette Deep Brain Stimulation.
Tremor and other hyperkinetic movements (New York, N.Y.). 10 [DOI] 10.5334/tohm.140. [PMID] 32775032.
2020
Letter: Evaluation and Surgical Treatment of Functional Neurosurgery Patients With Implanted Deep Brain Stimulation and Vagus Nerve Stimulation Pulse Generators During the COVID-19 Pandemic.
Neurosurgery. 87(2):E222-E226 [DOI] 10.1093/neuros/nyaa185. [PMID] 32379319.
2020
Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson’s disease: 5 years and beyond.
Journal of neurosurgery. 1-10 [DOI] 10.3171/2020.6.JNS20617. [PMID] 33035998.
2020
Long-term Parkinson’s disease quality of life after staged DBS: STN vs GPi and first vs second lead
npj Parkinson's Disease. 6(1) [DOI] 10.1038/s41531-020-0115-3. [PMID] 32656315.
2020
Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor.
Neurology. 94(10):e1073-e1084 [DOI] 10.1212/WNL.0000000000008875. [PMID] 32047071.
2020
Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
Movement disorders : official journal of the Movement Disorder Society. 35(8):1388-1395 [DOI] 10.1002/mds.28060. [PMID] 32357259.
2020
Motor outcomes and adverse effects of deep brain stimulation for dystonic tremor: A systematic review.
Parkinsonism & related disorders. 76:32-41 [DOI] 10.1016/j.parkreldis.2020.06.008. [PMID] 32559631.
2020
Neurophysiological Correlates of Gait in the Human Basal Ganglia and the PPN Region in Parkinson’s Disease.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00194. [PMID] 32581744.
2020
Parkinson’s disease motor subtype changes during 20 years of follow-up.
Parkinsonism & related disorders. 76:104-107 [DOI] 10.1016/j.parkreldis.2019.05.024. [PMID] 31129020.
2020
Parkinson’s disease motor subtypes and bilateral GPi deep brain stimulation: One-year outcomes.
Parkinsonism & related disorders. 75:7-13 [DOI] 10.1016/j.parkreldis.2020.05.004. [PMID] 32428801.
2020
Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus
The Journal of Neuroscience. 40(14):2859-2867 [DOI] 10.1523/jneurosci.2113-19.2020.
2020
Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus
The Journal of Neuroscience. 40(14):2859-2867 [DOI] 10.1523/jneurosci.2113-19.2020.
2020
Patient-centred management of Parkinson’s disease – Authors’ reply.
The Lancet. Neurology. 19(11):889-890 [DOI] 10.1016/S1474-4422(20)30360-4. [PMID] 33098792.
2020
Pavlovian bias in Parkinson’s disease: an objective marker of impulsivity that modulates with deep brain stimulation.
Scientific reports. 10(1) [DOI] 10.1038/s41598-020-69760-y. [PMID] 32778775.
2020
Postmortem Dissections of Common Targets for Lesion and Deep Brain Stimulation Surgeries.
Neurosurgery. 86(6):860-872 [DOI] 10.1093/neuros/nyz318. [PMID] 31504849.
2020
Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00054. [PMID] 32292333.
2020
Quality of life outcomes after deep brain stimulation in dystonia: A systematic review.
Parkinsonism & related disorders. 70:82-93 [DOI] 10.1016/j.parkreldis.2019.11.016. [PMID] 31767450.
2020
Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis.
Journal of neurology, neurosurgery, and psychiatry. 91(9):938-944 [DOI] 10.1136/jnnp-2019-322575. [PMID] 32732389.
2020
Quantitative Separation of Tremor and Ataxia in Essential Tremor.
Annals of neurology. 88(2):375-387 [DOI] 10.1002/ana.25781. [PMID] 32418250.
2020
Recommendations for Deep Brain Stimulation Device Management During a Pandemic.
Journal of Parkinson's disease. 10(3):903-910 [DOI] 10.3233/JPD-202072. [PMID] 32333552.
2020
Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease.
Journal of Parkinson's disease. 10(3):1087-1098 [DOI] 10.3233/JPD-202078. [PMID] 32444563.
2020
Reply to: “Toward a Personalized Approach to Parkinson’s Cell Therapy”.
Movement disorders : official journal of the Movement Disorder Society. 35(11):2120-2121 [DOI] 10.1002/mds.28329. [PMID] 33463751.
2020
Secondary Worsening Following DYT1 Dystonia Deep Brain Stimulation: A Multi-country Cohort.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00242. [PMID] 32670041.
2020
Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society. 35(8):1312-1314 [DOI] 10.1002/mds.28187. [PMID] 32529662.
2020
STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s Disease.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.578615. [PMID] 33192410.
2020
Structural connectivity predicts clinical outcomes of deep brain stimulation for Tourette syndrome.
Brain : a journal of neurology. 143(8):2607-2623 [DOI] 10.1093/brain/awaa188. [PMID] 32653920.
2020
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson’s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
The Lancet. Neurology. 19(6):491-501 [DOI] 10.1016/S1474-4422(20)30108-3. [PMID] 32470421.
2020
The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders.
JAMA neurology. 77(8):927-928 [DOI] 10.1001/jamaneurol.2020.1452. [PMID] 32329796.
2020
The UF Deep Brain Stimulation Cognitive Rating Scale (DBS-CRS): Clinical Decision Making, Validity, and Outcomes.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.578216. [PMID] 33132886.
2020
Three-Year Gait and Axial Outcomes of Bilateral STN and GPi Parkinson’s Disease Deep Brain Stimulation.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00001. [PMID] 32116598.
2020
Time for a New Image of Parkinson Disease.
JAMA neurology. 77(11):1345-1346 [DOI] 10.1001/jamaneurol.2020.2412. [PMID] 32716484.
2020
Ultrahigh-Performance Liquid Chromatography-High-Resolution Mass Spectrometry Metabolomics and Lipidomics Study of Stool from Transgenic Parkinson’s Disease Mice Following Immunotherapy.
Journal of proteome research. 19(1):424-431 [DOI] 10.1021/acs.jproteome.9b00605. [PMID] 31713431.
2020
Variations in hospitalization rates across Parkinson’s Foundation Centers of Excellence.
Parkinsonism & related disorders. 81:123-128 [DOI] 10.1016/j.parkreldis.2020.09.006. [PMID] 33120073.
2019
A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Parkinsonism & related disorders. 63:195-198 [DOI] 10.1016/j.parkreldis.2019.02.035. [PMID] 30837195.
2019
A review of basal ganglia circuits and physiology: Application to deep brain stimulation.
Parkinsonism & related disorders. 59:9-20 [DOI] 10.1016/j.parkreldis.2019.01.009. [PMID] 30658883.
2019
A Review of Cognitive Outcomes Across Movement Disorder Patients Undergoing Deep Brain Stimulation.
Frontiers in neurology. 10 [DOI] 10.3389/fneur.2019.00419. [PMID] 31133956.
2019
An Unusual Case of Essential Tremor Deep Brain Stimulation: Where is the Lead?
Tremor and other hyperkinetic movements (New York, N.Y.). 9 [DOI] 10.7916/d8-xj6w-cm53. [PMID] 30867977.
2019
Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.
Parkinsonism & related disorders. 60:126-132 [DOI] 10.1016/j.parkreldis.2018.09.004. [PMID] 30220556.
2019
Challenges in Defining Inappropriate Medication Use in Parkinson Disease Dementia.
JAMA neurology. 76(1):17-19 [DOI] 10.1001/jamaneurol.2018.2826. [PMID] 30285044.
2019
Changes in Midline Tremor and Gait Following Deep Brain Stimulation for Essential Tremor.
Tremor and other hyperkinetic movements (New York, N.Y.). 9 [DOI] 10.7916/tohm.v0.684. [PMID] 31565538.
2019
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
Neurology. 92(19):907-915 [DOI] 10.1212/WNL.0000000000007467. [PMID] 31061209.
2019
Cortical dynamics within and between parietal and motor cortex in essential tremor.
Movement disorders : official journal of the Movement Disorder Society. 34(1):95-104 [DOI] 10.1002/mds.27522. [PMID] 30345712.
2019
Deep Brain Stimulation for Obesity: A Review and Future Directions.
Frontiers in neuroscience. 13 [DOI] 10.3389/fnins.2019.00323. [PMID] 31057350.
2019
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.
The Lancet. Digital health. 1(5):e222-e231 [DOI] 10.1016/s2589-7500(19)30105-0. [PMID] 32259098.
2019
Effects of a Cycling Dual Task on Emotional Word Choice in Parkinson’s Disease.
Journal of speech, language, and hearing research : JSLHR. 62(6):1951-1958 [DOI] 10.1044/2019_JSLHR-L-18-0428. [PMID] 31170353.
2019
Emerging therapies in Parkinson disease – repurposed drugs and new approaches.
Nature reviews. Neurology. 15(4):204-223 [DOI] 10.1038/s41582-019-0155-7. [PMID] 30867588.
2019
Everyday functioning in Parkinson’s disease: Evidence from the Revised-Observed Tasks of Daily Living (OTDL-R).
Parkinsonism & related disorders. 60:167-170 [DOI] 10.1016/j.parkreldis.2018.08.026. [PMID] 30190102.
2019
Fornix-Region Deep Brain Stimulation-Induced Memory Flashbacks in Alzheimer’s Disease.
The New England journal of medicine. 381(8):783-785 [DOI] 10.1056/NEJMc1905240. [PMID] 31433930.
2019
Gait worsening and the microlesion effect following deep brain stimulation for essential tremor.
Journal of neurology, neurosurgery, and psychiatry. 90(8):913-919 [DOI] 10.1136/jnnp-2018-319723. [PMID] 30846538.
2019
Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study.
Journal of neurology, neurosurgery, and psychiatry. 90(10):1078-1090 [DOI] 10.1136/jnnp-2019-320379. [PMID] 31129620.
2019
Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life study.
Parkinsonism & related disorders. 64:249-255 [DOI] 10.1016/j.parkreldis.2019.04.024. [PMID] 31060987.
2019
Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.
The American journal of psychiatry. 176(3):217-227 [DOI] 10.1176/appi.ajp.2018.18070857. [PMID] 30818990.
2019
Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson’s Disease.
Frontiers in neurology. 10 [DOI] 10.3389/fneur.2019.00086. [PMID] 30863353.
2019
Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.
Human brain mapping. 40(17):5094-5107 [DOI] 10.1002/hbm.24760. [PMID] 31403737.
2019
Parkinson’s disease: Diagnosis and appreciation of comorbidities.
Handbook of clinical neurology. 167:257-277 [DOI] 10.1016/B978-0-12-804766-8.00014-5. [PMID] 31753136.
2019
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.
Neurology. 92(19):896-906 [DOI] 10.1212/WNL.0000000000007466. [PMID] 31061208.
2019
Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics.
Frontiers in neuroscience. 13 [DOI] 10.3389/fnins.2019.00936. [PMID] 31572109.
2019
Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson’s disease patients with suboptimal response to deep brain stimulation.
Annals of clinical and translational neurology. 6(10):1989-1995 [DOI] 10.1002/acn3.50889. [PMID] 31518070.
2019
Square Biphasic Pulse Deep Brain Stimulation for Parkinson’s Disease: The BiP-PD Study.
Frontiers in human neuroscience. 13 [DOI] 10.3389/fnhum.2019.00368. [PMID] 31680918.
2019
STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis.
Parkinsonism & related disorders. 58:56-62 [DOI] 10.1016/j.parkreldis.2018.08.017. [PMID] 30177491.
2019
Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects.
Journal of neurology. 266(2):289-297 [DOI] 10.1007/s00415-018-8936-2. [PMID] 29909467.
2019
The Functional Role of Thalamocortical Coupling in the Human Motor Network
The Journal of Neuroscience. 39(41):8124-8134 [DOI] 10.1523/jneurosci.1153-19.2019.
2019
The Functional Role of Thalamocortical Coupling in the Human Motor Network
The Journal of Neuroscience. 39(41):8124-8134 [DOI] 10.1523/jneurosci.1153-19.2019.
2019
The Primary Gait Screen in Parkinson’s disease: Comparison to standardized measures.
Gait & posture. 73:71-73 [DOI] 10.1016/j.gaitpost.2019.07.132. [PMID] 31301561.
2019
Tips for Choosing a Deep Brain Stimulation Device.
JAMA neurology. 76(7):749-750 [DOI] 10.1001/jamaneurol.2019.0849. [PMID] 31034008.
2018
A method for pre-operative single-subject thalamic segmentation based on probabilistic tractography for essential tremor deep brain stimulation.
Neuroradiology. 60(3):303-309 [DOI] 10.1007/s00234-017-1972-2. [PMID] 29307012.
2018
A widespread visually-sensitive functional network relates to symptoms in essential tremor.
Brain : a journal of neurology. 141(2):472-485 [DOI] 10.1093/brain/awx338. [PMID] 29293948.
2018
Analysis of shared heritability in common disorders of the brain.
Science (New York, N.Y.). 360(6395) [DOI] 10.1126/science.aap8757. [PMID] 29930110.
2018
Automated Affect Detection in Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Pilot Study.
Proceedings of the … ACM International Conference on Multimodal Interaction. ICMI (Conference). 2018:40-44 [DOI] 10.1145/3242969.3243023. [PMID] 30511050.
2018
Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
NeuroImage. Clinical. 19:559-571 [DOI] 10.1016/j.nicl.2018.05.021. [PMID] 29984164.
2018
Bilateral Basal Ganglia Necrosis Secondary to Methamphetamine.
Movement disorders clinical practice. 5(5):555-556 [DOI] 10.1002/mdc3.12649. [PMID] 30515446.
2018
Deep Brain Stimulation associated gliosis: A post-mortem study.
Parkinsonism & related disorders. 54:51-55 [DOI] 10.1016/j.parkreldis.2018.04.009. [PMID] 29653910.
2018
Deep Brain Stimulation at Variable Frequency to Improve Motor Outcomes in Parkinson’s Disease.
Movement disorders clinical practice. 5(5):538-541 [DOI] 10.1002/mdc3.12658. [PMID] 30637270.
2018
Deep Brain Stimulation for Parkinson Disease Dementia: A New Frontier?
JAMA neurology. 75(2):152-153 [DOI] 10.1001/jamaneurol.2017.3798. [PMID] 29255840.
2018
Deep Brain Stimulation Management of Essential Tremor with Dystonic Features.
Tremor and other hyperkinetic movements (New York, N.Y.). 8 [DOI] 10.7916/D8P85VBQ. [PMID] 29971197.
2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.
Journal of Alzheimer's disease : JAD. 64(2):597-606 [DOI] 10.3233/JAD-180121. [PMID] 29914028.
2018
Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry.
JAMA neurology. 75(3):353-359 [DOI] 10.1001/jamaneurol.2017.4317. [PMID] 29340590.
2018
Globus Pallidum DBS for Task-Specific Dystonia in a Professional Golfer.
Tremor and other hyperkinetic movements (New York, N.Y.). 8 [DOI] 10.7916/D83X9Q9D. [PMID] 30402336.
2018
Globus pallidus internus deep brain stimulation induces tremor in Parkinson’s disease: A paradoxical phenomenon.
Journal of the neurological sciences. 392:102-104 [DOI] 10.1016/j.jns.2018.07.005. [PMID] 30036780.
2018
Longitudinal Follow-up of Impedance Drift in Deep Brain Stimulation Cases.
Tremor and other hyperkinetic movements (New York, N.Y.). 8 [DOI] 10.7916/D8M62XTC. [PMID] 29607241.
2018
Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson’s Disease: Current Progress and Future Perspectives.
Analytical chemistry. 90(5):2979-2986 [DOI] 10.1021/acs.analchem.7b04084. [PMID] 29384654.
2018
Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 129(10):2215-2216 [DOI] 10.1016/j.clinph.2018.07.024. [PMID] 30131211.
2018
Multimodal neuroimaging and behavioral assessment of α-synuclein polymorphism rs356219 in older adults.
Neurobiology of aging. 66:32-39 [DOI] 10.1016/j.neurobiolaging.2018.02.001. [PMID] 29505953.
2018
Neuromedicine Service and Science Hub Model.
JAMA neurology. 75(3):271-272 [DOI] 10.1001/jamaneurol.2017.3976. [PMID] 29297000.
2018
Non-motor Characterization of the Basal Ganglia: Evidence From Human and Non-human Primate Electrophysiology.
Frontiers in neuroscience. 12 [DOI] 10.3389/fnins.2018.00385. [PMID] 30026679.
2018
Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease: A clinical review.
Movement disorders : official journal of the Movement Disorder Society. 33(1):10-20 [DOI] 10.1002/mds.27098. [PMID] 28960543.
2018
Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystonia.
Journal of neurology, neurosurgery, and psychiatry. 89(12):1296-1300 [DOI] 10.1136/jnnp-2017-317098. [PMID] 29326293.
2018
Potential indications for deep brain stimulation in neurological disorders: an evolving field.
European journal of neurology. 25(3):434-e30 [DOI] 10.1111/ene.13548. [PMID] 29266596.
2018
Reply: Visually-sensitive networks in essential tremor: evidence from structural and functional imaging.
Brain : a journal of neurology. 141(6) [DOI] 10.1093/brain/awy096. [PMID] 29659746.
2018
Report of a patient undergoing chronic responsive deep brain stimulation for Tourette syndrome: proof of concept.
Journal of neurosurgery. 129(2):308-314 [DOI] 10.3171/2017.6.JNS17626. [PMID] 28960154.
2018
Segmentation of the Globus Pallidus Internus Using Probabilistic Diffusion Tractography for Deep Brain Stimulation Targeting in Parkinson Disease
American Journal of Neuroradiology. 39(6):1127-1134 [DOI] 10.3174/ajnr.a5641.
2018
Square biphasic pulse deep brain stimulation for essential tremor: The BiP tremor study.
Parkinsonism & related disorders. 46:41-46 [DOI] 10.1016/j.parkreldis.2017.10.015. [PMID] 29102253.
2018
Structural connectivity-based segmentation of the thalamus and prediction of tremor improvement following thalamic deep brain stimulation of the ventral intermediate nucleus.
NeuroImage. Clinical. 20:1266-1273 [DOI] 10.1016/j.nicl.2018.10.009. [PMID] 30318403.
2018
Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson’s Disease.
Journal of the International Neuropsychological Society : JINS. 24(3):269-282 [DOI] 10.1017/S1355617717001011. [PMID] 29032789.
2018
The Emerging Evidence of the Parkinson Pandemic.
Journal of Parkinson's disease. 8(s1):S3-S8 [DOI] 10.3233/JPD-181474. [PMID] 30584159.
2018
Translating Temporal Interference Brain Stimulation to Treat Neurological and Psychiatric Conditions.
JAMA neurology. 75(11):1307-1308 [DOI] 10.1001/jamaneurol.2018.2760. [PMID] 30264149.
2018
Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor.
Movement disorders clinical practice. 5(1):75-82 [DOI] 10.1002/mdc3.12565. [PMID] 30363386.
2017
A marked point process approach for identifying neural correlates of tics in Tourette Syndrome.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2017:4375-4378 [DOI] 10.1109/EMBC.2017.8037825. [PMID] 29060866.
2017
A Marked Point Process Framework for Extracellular Electrical Potentials.
Frontiers in systems neuroscience. 11 [DOI] 10.3389/fnsys.2017.00095. [PMID] 29326562.
2017
A new non-surgical approach for deep-brain stimulation.
The Lancet. Neurology. 16(8) [DOI] 10.1016/S1474-4422(17)30224-7. [PMID] 28668374.
2017
A pilot trial of square biphasic pulse deep brain stimulation for dystonia: The BIP dystonia study.
Movement disorders : official journal of the Movement Disorder Society. 32(4):615-618 [DOI] 10.1002/mds.26906. [PMID] 28195407.
2017
Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study.
Journal of the International Neuropsychological Society : JINS. 23(4):322-331 [DOI] 10.1017/S1355617717000017. [PMID] 28162137.
2017
Considering Spastic Paraplegia Type 7 and Adult-Onset Alexander Disease.
JAMA neurology. 74(7):868-869 [DOI] 10.1001/jamaneurol.2017.0430. [PMID] 28459923.
2017
Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson’s Disease.
Seminars in neurology. 37(2):205-214 [DOI] 10.1055/s-0037-1601893. [PMID] 28511261.
2017
Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.
Movement disorders clinical practice. 4(2):191-197 [DOI] 10.1002/mdc3.12382. [PMID] 28944256.
2017
Emotion modulation of the startle reflex in essential tremor: Blunted reactivity to unpleasant and pleasant pictures.
Parkinsonism & related disorders. 34:54-58 [DOI] 10.1016/j.parkreldis.2016.11.003. [PMID] 27887893.
2017
Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank.
Frontiers in neuroscience. 11 [DOI] 10.3389/fnins.2017.00734. [PMID] 29416498.
2017
Focused stimulation of dorsal subthalamic nucleus improves reactive inhibitory control of action impulses.
Neuropsychologia. 99:37-47 [DOI] 10.1016/j.neuropsychologia.2017.02.016. [PMID] 28237741.
2017
Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.
Movement disorders : official journal of the Movement Disorder Society. 32(10):1457-1464 [DOI] 10.1002/mds.27100. [PMID] 28714593.
2017
Freezing-of-Gait detection using temporal, spatial, and physiological features with a support-vector-machine classifier.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2017:2867-2870 [DOI] 10.1109/EMBC.2017.8037455. [PMID] 29060496.
2017
Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.
Human brain mapping. 38(9):4563-4573 [DOI] 10.1002/hbm.23684. [PMID] 28594097.
2017
High-voltage VIM Region Deep Brain Stimulation Mimicking Progressive Supranuclear Palsy.
Tremor and other hyperkinetic movements (New York, N.Y.). 7 [DOI] 10.7916/D80G3QWB. [PMID] 28373925.
2017
Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.
PloS one. 12(7) [DOI] 10.1371/journal.pone.0180425. [PMID] 28683150.
2017
Improved cognition while cycling in Parkinson’s disease patients and healthy adults.
Brain and cognition. 113:23-31 [DOI] 10.1016/j.bandc.2017.01.002. [PMID] 28088064.
2017
Impulsivity in Parkinson’s disease is associated with altered subthalamic but not globus pallidus internus activity.
Journal of neurology, neurosurgery, and psychiatry. 88(11):968-970 [DOI] 10.1136/jnnp-2016-315325. [PMID] 28822983.
2017
Management of Elevated Therapeutic Impedances on Deep Brain Stimulation Leads.
Tremor and other hyperkinetic movements (New York, N.Y.). 7 [DOI] 10.7916/D8BR94MV. [PMID] 28983423.
2017
Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs.
JAMA. 318(9):791-792 [DOI] 10.1001/jama.2017.7914. [PMID] 28828469.
2017
Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson’s disease: a longitudinal analysis.
The Clinical neuropsychologist. 31(3):654-675 [DOI] 10.1080/13854046.2016.1251973. [PMID] 27813459.
2017
Measures of impulsivity in Parkinson’s disease decrease after DBS in the setting of stable dopamine therapy.
Parkinsonism & related disorders. 44:13-17 [DOI] 10.1016/j.parkreldis.2017.08.006. [PMID] 28827010.
2017
Medicinal Cannabis for Parkinson’s Disease: Practices, Beliefs, and Attitudes Among Providers at National Parkinson Foundation Centers of Excellence.
Movement disorders clinical practice. 4(1):90-95 [DOI] 10.1002/mdc3.12359. [PMID] 30713951.
2017
Motor subtype changes in early Parkinson’s disease.
Parkinsonism & related disorders. 43:67-72 [DOI] 10.1016/j.parkreldis.2017.07.018. [PMID] 28754232.
2017
Neuropsychological outcomes from constant current deep brain stimulation for Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 32(3):433-440 [DOI] 10.1002/mds.26827. [PMID] 27753157.
2017
Parkinson’s disease diffusion MRI is not affected by acute antiparkinsonian medication.
NeuroImage. Clinical. 14:417-421 [DOI] 10.1016/j.nicl.2017.02.012. [PMID] 28275542.
2017
Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
PloS one. 12(9) [DOI] 10.1371/journal.pone.0183711. [PMID] 28902876.
2017
Progression marker of Parkinson’s disease: a 4-year multi-site imaging study.
Brain : a journal of neurology. 140(8):2183-2192 [DOI] 10.1093/brain/awx146. [PMID] 28899020.
2017
Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.
Neuron. 94(6):1101-1111.e7 [DOI] 10.1016/j.neuron.2017.06.010. [PMID] 28641109.
2017
Reengineering deep brain stimulation for movement disorders: Emerging technologies.
Current opinion in biomedical engineering. 4:97-105 [DOI] 10.1016/j.cobme.2017.09.001. [PMID] 29450404.
2017
Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.
The Lancet. Neurology. 16(9):691-700 [DOI] 10.1016/S1474-4422(17)30166-7. [PMID] 28642125.
2017
Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial.
Parkinsonism & related disorders. 40:18-26 [DOI] 10.1016/j.parkreldis.2017.03.017. [PMID] 28400200.
2017
Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry.
Movement disorders : official journal of the Movement Disorder Society. 32(8):1240-1244 [DOI] 10.1002/mds.27082. [PMID] 28631862.
2017
The human subthalamic nucleus and globus pallidus internus differentially encode reward during action control.
Human brain mapping. 38(4):1952-1964 [DOI] 10.1002/hbm.23496. [PMID] 28130916.
2017
The ice test to differentiate essential tremor from Parkinson’s disease tremor.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 128(11):2181-2183 [DOI] 10.1016/j.clinph.2017.08.015. [PMID] 28946133.
2017
The Parkinson’s Active Living (PAL) Program.
Journal of geriatric psychiatry and neurology. 30(1):11-25 [DOI] 10.1177/0891988716673467. [PMID] 28248557.
2017
The Problem of Funding Off-label Deep Brain Stimulation: Bait-and-Switch Tactics and the Need for Policy Reform.
JAMA neurology. 74(1):9-10 [DOI] 10.1001/jamaneurol.2016.2530. [PMID] 27820615.
2017
Update on Parkinson’s Disease.
Seminars in neurology. 37(2):107-108 [DOI] 10.1055/s-0037-1603207. [PMID] 28511250.
2017
Variable frequency stimulation of subthalamic nucleus in Parkinson’s disease: Rationale and hypothesis.
Parkinsonism & related disorders. 39:27-30 [DOI] 10.1016/j.parkreldis.2017.03.015. [PMID] 28392298.
2017
Voluntary upregulation of reflex cough is possible in healthy older adults and Parkinson’s disease.
Journal of applied physiology (Bethesda, Md. : 1985). 123(1):19-26 [DOI] 10.1152/japplphysiol.00612.2016. [PMID] 28360120.
2016
A Method for Automated Classification of Parkinson’s Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.
PloS one. 11(6) [DOI] 10.1371/journal.pone.0155764. [PMID] 27280486.
2016
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease.
Journal of Alzheimer's disease : JAD. 54(2):777-87 [DOI] 10.3233/JAD-160017. [PMID] 27567810.
2016
A Review and Update on Tourette Syndrome: Where Is the Field Headed?
Current neurology and neuroscience reports. 16(4) [DOI] 10.1007/s11910-016-0633-x. [PMID] 26936259.
2016
Aerobic Exercise Improves Mood, Cognition, and Language Function in Parkinson’s Disease: Results of a Controlled Study.
Journal of the International Neuropsychological Society : JINS. 22(9):878-889 [PMID] 27655232.
2016
Apathy, Novelty Processing, and the P3 Potential in Parkinson’s Disease.
Frontiers in neurology. 7 [DOI] 10.3389/fneur.2016.00095. [PMID] 27445962.
2016
Association between antidepressants and falls in Parkinson’s disease.
Journal of neurology. 263(1):76-82 [DOI] 10.1007/s00415-015-7947-5. [PMID] 26514836.
2016
Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
Parkinsonism & related disorders. 22:102-5 [DOI] 10.1016/j.parkreldis.2015.11.016. [PMID] 26627941.
2016
Atrophy is a Real Phenomenon that Can Result in Changes in Deep Brain Stimulation Outcome.
Journal of epilepsy research. 6(1):42-3 [DOI] 10.14581/jer.16009. [PMID] 27390681.
2016
Beyond patient-centered care: person-centered care for Parkinson’s disease.
NPJ Parkinson's disease. 2 [DOI] 10.1038/npjparkd.2016.19. [PMID] 28725700.
2016
Comparison of Two Methods for Inducing Reflex Cough in Patients With Parkinson’s Disease, With and Without Dysphagia.
Dysphagia. 31(1):66-73 [DOI] 10.1007/s00455-015-9659-5. [PMID] 26497650.
2016
Cystic Lesions as a Rare Complication of Deep Brain Stimulation.
Movement disorders clinical practice. 3(1):87-90 [DOI] 10.1002/mdc3.12230. [PMID] 30363583.
2016
Deep Brain Stimulation Battery Longevity: Comparison of Monopolar Versus Bipolar Stimulation Modes.
Movement disorders clinical practice. 3(4):359-366 [PMID] 27617270.
2016
Deep brain stimulation for the treatment of uncommon tremor syndromes.
Expert review of neurotherapeutics. 16(8):983-97 [DOI] 10.1080/14737175.2016.1194756. [PMID] 27228280.
2016
Deep brain stimulation improves gait velocity in Parkinson’s disease: a systematic review and meta-analysis.
Journal of neurology. 263(6):1195-203 [DOI] 10.1007/s00415-016-8129-9. [PMID] 27126451.
2016
Deep Brain Stimulation in a Case of Mitochondrial Disease.
Movement disorders clinical practice. 3(2):139-145 [DOI] 10.1002/mdc3.12241. [PMID] 30713906.
2016
Diagnosing Parkinson Disease.
Continuum (Minneapolis, Minn.). 22(4 Movement Disorders):1047-63 [DOI] 10.1212/CON.0000000000000345. [PMID] 27495197.
2016
Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.
Movement disorders : official journal of the Movement Disorder Society. 31(3):290-6 [DOI] 10.1002/mds.26500. [PMID] 26952118.
2016
Free-water and BOLD imaging changes in Parkinson’s disease patients chronically treated with a MAO-B inhibitor.
Human brain mapping. 37(8):2894-903 [DOI] 10.1002/hbm.23213. [PMID] 27089850.
2016
Free-water imaging in Parkinson’s disease and atypical parkinsonism.
Brain : a journal of neurology. 139(Pt 2):495-508 [DOI] 10.1093/brain/awv361. [PMID] 26705348.
2016
Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.
Neurology. 87(7):709-17 [DOI] 10.1212/WNL.0000000000002985. [PMID] 27421545.
2016
Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson’s Disease.
PloS one. 11(1) [DOI] 10.1371/journal.pone.0147332. [PMID] 26784744.
2016
High rates of fatigue and sleep disturbances in dystonia.
The International journal of neuroscience. 126(10):928-35 [DOI] 10.3109/00207454.2015.1085035. [PMID] 26289935.
2016
Interdisciplinary Parkinson’s Disease Deep Brain Stimulation Screening and the Relationship to Unintended Hospitalizations and Quality of Life.
PloS one. 11(5) [DOI] 10.1371/journal.pone.0153785. [PMID] 27159519.
2016
Is Blast Injury a Modern Phenomenon?: Early Historical Descriptions of Mining and Volcanic Traumatic Brain Injury With Relevance to Modern Terrorist Attacks and Military Warfare.
The neurologist. 21(2):19-22 [DOI] 10.1097/NRL.0000000000000068. [PMID] 26926850.
2016
Laterality of repetitive finger movement performance and clinical features of Parkinson’s disease.
Human movement science. 49:116-23 [DOI] 10.1016/j.humov.2016.06.015. [PMID] 27371918.
2016
Mood Differences Among Parkinson’s Disease Patients With Mild Cognitive Impairment.
The Journal of neuropsychiatry and clinical neurosciences. 28(3):211-6 [DOI] 10.1176/appi.neuropsych.15090221. [PMID] 26792098.
2016
Motivational engagement in Parkinson’s disease: Preparation for motivated action.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology. 99:24-32 [DOI] 10.1016/j.ijpsycho.2015.11.014. [PMID] 26659013.
2016
Occurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study.
Tremor and other hyperkinetic movements (New York, N.Y.). 6 [PMID] 27830106.
2016
Parkinson’s disease and the Stroop color word test: processing speed and interference algorithms.
The Clinical neuropsychologist. 30(7):1104-17 [DOI] 10.1080/13854046.2016.1188989. [PMID] 27264121.
2016
Parkinson’s disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.
Neurodegenerative disease management. 6(4):319-30 [DOI] 10.2217/nmt-2016-0009. [PMID] 27408981.
2016
Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology.
Stereotactic and functional neurosurgery. 94(5):298-306 [PMID] 27723662.
2016
Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging.
Stereotactic and functional neurosurgery. 94(5):307-319 [PMID] 27728909.
2016
Post-mortem Findings in Huntington’s Deep Brain Stimulation: A Moving Target Due to Atrophy.
Tremor and other hyperkinetic movements (New York, N.Y.). 6 [DOI] 10.7916/D8ZP462H. [PMID] 27127722.
2016
Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.
Frontiers in integrative neuroscience. 10 [PMID] 27920671.
2016
Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.
Frontiers in neuroscience. 10 [DOI] 10.3389/fnins.2016.00119. [PMID] 27092042.
2016
Randomized, Blinded Pilot Testing of Nonconventional Stimulation Patterns and Shapes in Parkinson’s Disease and Essential Tremor: Evidence for Further Evaluating Narrow and Biphasic Pulses.
Neuromodulation : journal of the International Neuromodulation Society. 19(4):343-56 [DOI] 10.1111/ner.12397. [PMID] 27000764.
2016
Reflex Cough and Disease Duration as Predictors of Swallowing Dysfunction in Parkinson’s Disease.
Dysphagia. 31(6):757-764 [PMID] 27461481.
2016
Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.
PM & R : the journal of injury, function, and rehabilitation. 8(4):356-366 [DOI] 10.1016/j.pmrj.2015.08.009. [PMID] 26314233.
2016
Scheduled, intermittent stimulation of the thalamus reduces tics in Tourette syndrome.
Parkinsonism & related disorders. 29:35-41 [DOI] 10.1016/j.parkreldis.2016.05.033. [PMID] 27297737.
2016
Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder.
PloS one. 11(12) [DOI] 10.1371/journal.pone.0167875. [PMID] 27930748.
2016
State of the Art for Deep Brain Stimulation Therapy in Movement Disorders: A Clinical and Technological Perspective.
IEEE reviews in biomedical engineering. 9:219-33 [DOI] 10.1109/RBME.2016.2588399. [PMID] 27411228.
2016
Tailored deep brain stimulation optimization for improved airway protective outcomes in Parkinson’s disease.
Interdisciplinary neurosurgery : Advanced techniques and case management. 5:3-5 [PMID] 27795943.
2016
Thalamocortical network activity enables chronic tic detection in humans with Tourette syndrome.
NeuroImage. Clinical. 12:165-72 [DOI] 10.1016/j.nicl.2016.06.015. [PMID] 27419067.
2016
The Danger of Not Treating Parkinson Disease Psychosis.
JAMA neurology. 73(9) [DOI] 10.1001/jamaneurol.2016.2280. [PMID] 27400122.
2016
The International Deep Brain Stimulation Registry and Database for Gilles de la Tourette Syndrome: How Does It Work?
Frontiers in neuroscience. 10 [DOI] 10.3389/fnins.2016.00170. [PMID] 27199634.
2016
Tissue Response to Deep Brain Stimulation and Microlesion: A Comparative Study.
Neuromodulation : journal of the International Neuromodulation Society. 19(5):451-8 [DOI] 10.1111/ner.12406. [PMID] 27018335.
2016
Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series.
Journal of child neurology. 31(8):1027-35 [DOI] 10.1177/0883073816635749. [PMID] 27052971.
2015
A Polysomnographic Study of Parkinson’s Disease Sleep Architecture.
Parkinson's disease. 2015 [DOI] 10.1155/2015/570375. [PMID] 26504612.
2015
Abnormal tactile pressure perception in Parkinson’s disease.
Journal of clinical and experimental neuropsychology. 37(8):808-15 [DOI] 10.1080/13803395.2015.1060951. [PMID] 26313511.
2015
Anxiety and Depression Are Better Correlates of Parkinson’s Disease Quality of Life Than Apathy.
The Journal of neuropsychiatry and clinical neurosciences. 27(3):213-8 [DOI] 10.1176/appi.neuropsych.13120380. [PMID] 25162776.
2015
Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study.
Journal of neurology. 262(11):2528-38 [DOI] 10.1007/s00415-015-7877-2. [PMID] 26292793.
2015
Chasing tics in the human brain: development of open, scheduled and closed loop responsive approaches to deep brain stimulation for tourette syndrome.
Journal of clinical neurology (Seoul, Korea). 11(2):122-31 [DOI] 10.3988/jcn.2015.11.2.122. [PMID] 25851890.
2015
Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 35(1):16-21 [DOI] 10.1097/WNO.0000000000000167. [PMID] 25259863.
2015
Decreased Sensitivity To Cough Stimulus in Persons With Parkinson’s Disease and Dysphagia
Biological Psychology. 104
2015
Differences in Urge To Cough and Total Coughs Produced in Parkinson’s Disease Vs. Healthy Adults
Biological Psychology. 104:152-153
2015
Distinct functional and macrostructural brain changes in Parkinson’s disease and multiple system atrophy.
Human brain mapping. 36(3):1165-79 [DOI] 10.1002/hbm.22694. [PMID] 25413603.
2015
Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 30(9):1248-58 [DOI] 10.1002/mds.26294. [PMID] 26148135.
2015
Functional Brain Activity Relates to 0-3 and 3-8 Hz Force Oscillations in Essential Tremor.
Cerebral cortex (New York, N.Y. : 1991). 25(11):4191-202 [DOI] 10.1093/cercor/bhu142. [PMID] 24962992.
2015
Global attentional neglect of segmented lines in Parkinson’s disease.
Neurocase. 21(4):501-8 [DOI] 10.1080/13554794.2014.942671. [PMID] 25073971.
2015
How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease?
Archives of physical medicine and rehabilitation. 96(9):1728-32 [DOI] 10.1016/j.apmr.2015.03.021. [PMID] 25883039.
2015
Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients.
PloS one. 10(12) [DOI] 10.1371/journal.pone.0145623. [PMID] 26710099.
2015
Incidence and mortality trends of aspiration pneumonia in Parkinson’s disease in the United States, 1979-2010.
Parkinsonism & related disorders. 21(9):1082-6 [DOI] 10.1016/j.parkreldis.2015.06.020. [PMID] 26154915.
2015
Increased free water in the substantia nigra of Parkinson’s disease: a single-site and multi-site study.
Neurobiology of aging. 36(2):1097-104 [DOI] 10.1016/j.neurobiolaging.2014.10.029. [PMID] 25467638.
2015
Latent growth-curve analysis reveals that worsening Parkinson’s disease quality of life is driven by depression.
Neuropsychology. 29(4):603-609 [DOI] 10.1037/neu0000158. [PMID] 25365564.
2015
Longitudinal changes in free-water within the substantia nigra of Parkinson’s disease.
Brain : a journal of neurology. 138(Pt 8):2322-31 [DOI] 10.1093/brain/awv136. [PMID] 25981960.
2015
Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study.
Brain stimulation. 8(1):64-75 [DOI] 10.1016/j.brs.2014.10.011. [PMID] 25440578.
2015
Management of impulse control disorders in Parkinson’s disease: Controversies and future approaches.
Movement disorders : official journal of the Movement Disorder Society. 30(2):150-9 [DOI] 10.1002/mds.26099. [PMID] 25607799.
2015
Memory Similarities Between Essential Tremor and Parkinson’s Disease: A Final Common Pathway?
The Clinical neuropsychologist. 29(7):985-1001 [DOI] 10.1080/13854046.2015.1118553. [PMID] 26689342.
2015
Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson’s disease patients.
PloS one. 10(4) [DOI] 10.1371/journal.pone.0124356. [PMID] 25884484.
2015
Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions.
Neurobiology of aging. 36(2):1223.e1-2 [DOI] 10.1016/j.neurobiolaging.2014.08.033. [PMID] 25281017.
2015
Narrative Discourse Cohesion in Early Stage Parkinson’s Disease.
Journal of Parkinson's disease. 5(2):403-11 [DOI] 10.3233/JPD-140476. [PMID] 25757829.
2015
Novel targets and stimulation paradigms for deep brain stimulation.
Expert review of neurotherapeutics. 15(9):1067-80 [DOI] 10.1586/14737175.2015.1083421. [PMID] 26312646.
2015
Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson’s Disease: Considerations from a Pilot Study.
Journal of Parkinson's disease. 5(4):893-905 [DOI] 10.3233/JPD-150632. [PMID] 26683785.
2015
Person-Centered Care in the Home Setting for Parkinson’s Disease: Operation House Call Quality of Care Pilot Study.
Parkinson's disease. 2015 [DOI] 10.1155/2015/639494. [PMID] 26078912.
2015
Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What’s in the Pipeline.
The International journal of neuroscience. 125(7):475-85 [DOI] 10.3109/00207454.2014.999268. [PMID] 25526555.
2015
Proof of principle: Transformation approach alters caudate nucleus volume and structure-function associations.
Brain imaging and behavior. 9(4):744-53 [DOI] 10.1007/s11682-014-9332-x. [PMID] 25413122.
2015
Rate of aspiration pneumonia in hospitalized Parkinson’s disease patients: a cross-sectional study.
BMC neurology. 15 [DOI] 10.1186/s12883-015-0362-9. [PMID] 26141135.
2015
Repetitive finger movement performance differs among Parkinson’s disease, Progressive Supranuclear Palsy, and spinocerebellar ataxia.
Journal of clinical movement disorders. 2 [DOI] 10.1186/s40734-014-0015-y. [PMID] 26788342.
2015
Reply: The ‘cognitions’ index of the Parkinson’s disease questionnaire-39 relates to sleep disturbances and hallucinations.
Parkinsonism & related disorders. 21(3):351-2 [DOI] 10.1016/j.parkreldis.2014.12.002. [PMID] 25616693.
2015
Smile without euphoria induced by deep brain stimulation: a case report.
Neurocase. 21(6):674-8 [DOI] 10.1080/13554794.2014.973883. [PMID] 25360766.
2015
Steroid-responsive intracranial germinoma presenting as Holmes’ tremor: importance of a tissue diagnosis.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 22(5):911-3 [DOI] 10.1016/j.jocn.2014.11.013. [PMID] 25800941.
2015
Subthalamic nucleus–sensorimotor cortex functional connectivity in de novo and moderate Parkinson’s disease.
Neurobiology of aging. 36(1):462-9 [DOI] 10.1016/j.neurobiolaging.2014.07.004. [PMID] 25095723.
2015
Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson’s Disease with Verbal Memory Impairment.
PloS one. 10(7) [DOI] 10.1371/journal.pone.0133792. [PMID] 26208170.
2015
The Profile of Long-term Parkinson’s Disease Survivors with 20 Years of Disease Duration and Beyond.
Journal of Parkinson's disease. 5(2):313-9 [DOI] 10.3233/JPD-140515. [PMID] 25720446.
2015
The rationale driving the evolution of deep brain stimulation to constant-current devices.
Neuromodulation : journal of the International Neuromodulation Society. 18(2):85-8; discussion 88 [DOI] 10.1111/ner.12227. [PMID] 25171762.
2015
The Subthalamic Nucleus, Limbic Function, and Impulse Control.
Neuropsychology review. 25(4):398-410 [DOI] 10.1007/s11065-015-9306-9. [PMID] 26577509.
2015
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease.
Expert opinion on pharmacotherapy. 16(16):2449-64 [DOI] 10.1517/14656566.2015.1086747. [PMID] 26374094.
2015
Tourette syndrome deep brain stimulation: a review and updated recommendations.
Movement disorders : official journal of the Movement Disorder Society. 30(4):448-71 [DOI] 10.1002/mds.26094. [PMID] 25476818.
2015
Tractography Activation Patterns in Dorsolateral Prefrontal Cortex Suggest Better Clinical Responses in OCD DBS.
Frontiers in neuroscience. 9 [DOI] 10.3389/fnins.2015.00519. [PMID] 26834544.
2015
Unexpected dual task benefits on cycling in Parkinson disease and healthy adults: a neuro-behavioral model.
PloS one. 10(5) [DOI] 10.1371/journal.pone.0125470. [PMID] 25970607.
2015
Update on deep brain stimulation in Parkinson’s disease.
Translational neurodegeneration. 4 [DOI] 10.1186/s40035-015-0034-0. [PMID] 26257895.
2015
Weight loss and impact on quality of life in Parkinson’s disease.
PloS one. 10(5) [DOI] 10.1371/journal.pone.0124541. [PMID] 25938478.
2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
JAMA neurology. 71(5):543-52 [DOI] 10.1001/jamaneurol.2014.131. [PMID] 24664227.
2014
Acute and Chronic Mood and Apathy Outcomes from a randomized study of unilateral STN and GPi DBS.
PloS one. 9(12) [DOI] 10.1371/journal.pone.0114140. [PMID] 25469706.
2014
An eight-year clinic experience with clozapine use in a Parkinson’s disease clinic setting.
PloS one. 9(3) [DOI] 10.1371/journal.pone.0091545. [PMID] 24646688.
2014
Associations between cognitive and gait performance during single- and dual-task walking in people with Parkinson disease.
Physical therapy. 94(6):757-66 [DOI] 10.2522/ptj.20130251. [PMID] 24557652.
2014
Atrophy and other potential factors affecting long term deep brain stimulation response: a case series.
PloS one. 9(10) [DOI] 10.1371/journal.pone.0111561. [PMID] 25360599.
2014
Attentional resource allocation and swallowing safety in Parkinson’s disease: a dual task study.
Parkinsonism & related disorders. 20(4):439-43 [DOI] 10.1016/j.parkreldis.2013.12.011. [PMID] 24444532.
2014
Barriers to investigator-initiated deep brain stimulation and device research.
Neurology. 82(16):1465-73 [DOI] 10.1212/WNL.0000000000000345. [PMID] 24670888.
2014
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8KS6PPR. [PMID] 24932426.
2014
Cognitive declines after deep brain stimulation are likely to be attributable to more than caudate penetration and lead location.
Brain : a journal of neurology. 137(Pt 5) [DOI] 10.1093/brain/awu008. [PMID] 24519976.
2014
Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8H41Q4X. [PMID] 25562037.
2014
Comparison of voluntary and reflex cough effectiveness in Parkinson’s disease.
Parkinsonism & related disorders. 20(11):1226-30 [DOI] 10.1016/j.parkreldis.2014.09.010. [PMID] 25246315.
2014
Concordance and discriminatory power of cough measurement devices for individuals with Parkinson disease.
Chest. 145(5):1089-1096 [DOI] 10.1378/chest.13-0596. [PMID] 24264124.
2014
Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson’s disease.
Parkinsonism & related disorders. 20(4):360-9 [DOI] 10.1016/j.parkreldis.2013.10.030. [PMID] 24484618.
2014
Coordinate-based lead location does not predict Parkinson’s disease deep brain stimulation outcome.
PloS one. 9(4) [DOI] 10.1371/journal.pone.0093524. [PMID] 24691109.
2014
Correlations of apathy and depression with postural instability in Parkinson disease.
Journal of the neurological sciences. 338(1-2):162-5 [DOI] 10.1016/j.jns.2013.12.040. [PMID] 24461565.
2014
Decreased cough sensitivity and aspiration in Parkinson disease.
Chest. 146(5):1294-1299 [DOI] 10.1378/chest.14-0066. [PMID] 24968148.
2014
Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques.
The International journal of neuroscience. 124(6):394-402 [DOI] 10.3109/00207454.2013.852086. [PMID] 24099662.
2014
Deep Brain Stimulation for Tourette Syndrome: the Current State of the Field
Journal of Obsessive-Compulsive and Related Disorders. 3(4):401-406 [DOI] 10.1016/j.jocrd.2014.06.005.
2014
Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8542KQ5. [PMID] 25120941.
2014
Deep brain stimulation may improve quality of life in people with Parkinson’s disease without affecting caregiver burden.
Neuromodulation : journal of the International Neuromodulation Society. 17(2):126-32 [PMID] 24024760.
2014
Deep-brain stimulation–entering the era of human neural-network modulation.
The New England journal of medicine. 371(15):1369-73 [DOI] 10.1056/NEJMp1408779. [PMID] 25197963.
2014
Defining the clinically meaningful difference in gait speed in persons with Parkinson disease.
Journal of neurologic physical therapy : JNPT. 38(4):233-8 [DOI] 10.1097/NPT.0000000000000055. [PMID] 25198866.
2014
Detraining outcomes with expiratory muscle strength training in Parkinson disease.
Journal of rehabilitation research and development. 51(2):305-10 [DOI] 10.1682/JRRD.2013.05.0101. [PMID] 24933728.
2014
Driving errors in Parkinson’s disease: moving closer to predicting on-road outcomes.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association. 68(1):77-85 [DOI] 10.5014/ajot.2014.008698. [PMID] 24367958.
2014
I spy apraxic eyes in spinocerebellar ataxia type 2: a false-negative ataxia panel.
Movement disorders : official journal of the Movement Disorder Society. 29(3):426-7 [PMID] 24795923.
2014
Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery.
Journal of Parkinson's disease. 4(4):591-8 [DOI] 10.3233/JPD-140357. [PMID] 25035311.
2014
Increased precursor cell proliferation after deep brain stimulation for Parkinson’s disease: a human study.
PloS one. 9(3) [DOI] 10.1371/journal.pone.0088770. [PMID] 24594681.
2014
Influence of hypertension on neurocognitive domains in nondemented Parkinson’s disease patients.
Parkinson's disease. 2014 [DOI] 10.1155/2014/507529. [PMID] 24587937.
2014
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
Neurocase. 20(6):698-703 [DOI] 10.1080/13554794.2013.841952. [PMID] 24156388.
2014
Locomotor adaptation and locomotor adaptive learning in Parkinson’s disease and normal aging.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 125(2):313-9 [DOI] 10.1016/j.clinph.2013.07.003. [PMID] 23916406.
2014
Medicare coverage of investigational devices: the troubled path forward for deep brain stimulation.
JAMA neurology. 71(5):535-6 [PMID] 24590448.
2014
Mobility, mood and site of care impact health related quality of life in Parkinson’s disease.
Parkinsonism & related disorders. 20(3):274-9 [DOI] 10.1016/j.parkreldis.2013.10.004. [PMID] 24182524.
2014
MRI reveals brain abnormalities in drug-naive Parkinson’s disease.
Exercise and sport sciences reviews. 42(1):12-22 [DOI] 10.1249/JES.0000000000000003. [PMID] 24188978.
2014
Outcomes, management, and potential mechanisms of interleaving deep brain stimulation settings.
Parkinsonism & related disorders. 20(12):1434-7 [DOI] 10.1016/j.parkreldis.2014.10.011. [PMID] 25457819.
2014
Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?
Frontiers in neurology. 5 [DOI] 10.3389/fneur.2014.00243. [PMID] 25538673.
2014
Rationale and clinical pearls for primary care doctors referring patients for deep brain stimulation.
Gerontology. 60(1):38-48 [DOI] 10.1159/000354880. [PMID] 24193201.
2014
Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8XP72WF. [PMID] 24587970.
2014
Sequential voluntary cough and aspiration or aspiration risk in Parkinson’s disease.
Lung. 192(4):601-8 [DOI] 10.1007/s00408-014-9584-7. [PMID] 24792231.
2014
STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.
Movement disorders clinical practice. 1(1):24-35 [PMID] 24779023.
2014
Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder.
Neuromodulation : journal of the International Neuromodulation Society. 17(4):312-9; discussion 319 [DOI] 10.1111/ner.12141. [PMID] 24345303.
2014
Surgical treatment of dyskinesia in Parkinson’s disease.
Frontiers in neurology. 5 [DOI] 10.3389/fneur.2014.00065. [PMID] 24808889.
2014
Surgical treatment of Parkinson’s disease: patients, targets, devices, and approaches.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 11(1):47-59 [DOI] 10.1007/s13311-013-0235-0. [PMID] 24198187.
2014
Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis.
Dysphagia. 29(4):425-31 [DOI] 10.1007/s00455-014-9522-0. [PMID] 24652582.
2014
Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort.
Journal of clinical movement disorders. 1 [DOI] 10.1186/2054-7072-1-8. [PMID] 26788334.
2014
The “brittle response” to Parkinson’s disease medications: characterization and response to deep brain stimulation.
PloS one. 9(4) [DOI] 10.1371/journal.pone.0094856. [PMID] 24733172.
2014
The cognition and emotional well-being indices of the Parkinson’s disease questionnaire-39: what do they really measure?
Parkinsonism & related disorders. 20(11):1236-41 [DOI] 10.1016/j.parkreldis.2014.09.014. [PMID] 25260967.
2014
The Profile of Long-Term Parkinson’s Disease Survivors With 20 Years Disease Duration and Beyond
Movement Disorders. 29(14):1838-1839
2014
Three families with Perry syndrome from distinct parts of the world.
Parkinsonism & related disorders. 20(8):884-8 [DOI] 10.1016/j.parkreldis.2014.05.004. [PMID] 24881494.
2014
Timed up and go, cognitive, and quality-of-life correlates in Parkinson’s disease.
Archives of physical medicine and rehabilitation. 95(4):649-55 [DOI] 10.1016/j.apmr.2013.10.031. [PMID] 24291596.
2014
Treatment of advanced Parkinson’s disease.
Current opinion in neurology. 27(4):450-60 [DOI] 10.1097/WCO.0000000000000118. [PMID] 24978634.
2013
[Mechanism of action for deep brain stimulation and electrical neuro-network modulation (ENM)].
Rinsho shinkeigaku = Clinical neurology. 53(9):691-4 [PMID] 24097315.
2013
A Closer Look At Unilateral Versus Bilateral Deep Brain Stimulation: Results of the National Institutes of Health Compare Cohort (Vol 113, Pg 1224, 2010)
Journal of Neurosurgery. 119(4) [DOI] 10.3171/2013.7.JNS10312a.
2013
A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.
Tremor and other hyperkinetic movements (New York, N.Y.). 3 [DOI] 10.7916/D86W98SW. [PMID] 24255805.
2013
A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms.
JAMA neurology. 70(1):85-94 [DOI] 10.1001/jamaneurol.2013.580. [PMID] 23044532.
2013
An algorithm for management of deep brain stimulation battery replacements: devising a web-based battery estimator and clinical symptom approach.
Neuromodulation : journal of the International Neuromodulation Society. 16(2):147-53 [DOI] 10.1111/j.1525-1403.2012.00457.x. [PMID] 22646907.
2013
Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.
Neuromodulation : journal of the International Neuromodulation Society. 16(5):407-13; discussion 413 [DOI] 10.1111/ner.12052. [PMID] 23738501.
2013
Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson’s disease.
Neurocase. 19(6):587-91 [DOI] 10.1080/13554794.2012.713490. [PMID] 22934916.
2013
Deep brain stimulation (DBS) at the interface of neurology and psychiatry.
The Journal of clinical investigation. 123(11):4546-56 [DOI] 10.1172/JCI68341. [PMID] 24177464.
2013
Deep-brain stimulation for Parkinson’s disease.
The New England journal of medicine. 368(5):483-4 [DOI] 10.1056/NEJMc1214078. [PMID] 23363512.
2013
Delineation of motor and somatosensory thalamic subregions utilizing probabilistic diffusion tractography and electrophysiology.
Journal of magnetic resonance imaging : JMRI. 37(3):600-9 [DOI] 10.1002/jmri.23861. [PMID] 23060259.
2013
Differential and better response to deep brain stimulation of chorea compared to dystonia in Huntington’s disease.
Stereotactic and functional neurosurgery. 91(2):129-33 [DOI] 10.1159/000341070. [PMID] 23343665.
2013
Driving performance and behaviors: a comparison of gender differences in Parkinson’s disease.
Traffic injury prevention. 14(4):340-5 [DOI] 10.1080/15389588.2012.717730. [PMID] 23531256.
2013
Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of TFDP1: case report.
BMC medical genetics. 14 [DOI] 10.1186/1471-2350-14-70. [PMID] 23849371.
2013
Effect of lead trajectory on the response of essential head tremor to deep brain stimulation.
Parkinsonism & related disorders. 19(9):789-94 [DOI] 10.1016/j.parkreldis.2013.03.015. [PMID] 23742969.
2013
Emerging subspecialties in neurology: deep brain stimulation and electrical neuro-network modulation.
Neurology. 80(5):e47-50 [DOI] 10.1212/WNL.0b013e31827f0f91. [PMID] 23359377.
2013
Gait initiation impairments in both Essential Tremor and Parkinson’s disease.
Gait & posture. 38(4):956-61 [DOI] 10.1016/j.gaitpost.2013.05.001. [PMID] 23726428.
2013
Gait variability magnitude but not structure is altered in essential tremor.
Journal of biomechanics. 46(15):2682-7 [DOI] 10.1016/j.jbiomech.2013.07.039. [PMID] 24011360.
2013
Hedonic and behavioral deficits associated with apathy in Parkinson’s disease: potential treatment implications.
Movement disorders : official journal of the Movement Disorder Society. 28(9):1301-4 [DOI] 10.1002/mds.25496. [PMID] 23712560.
2013
High rates and the risk factors for emergency room visits and hospitalization in Parkinson’s disease.
Parkinsonism & related disorders. 19(11):949-54 [DOI] 10.1016/j.parkreldis.2013.06.006. [PMID] 23835430.
2013
Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation.
Parkinsonism & related disorders. 19(2):171-5 [DOI] 10.1016/j.parkreldis.2012.09.002. [PMID] 23062997.
2013
Interlimb coordination is impaired during walking in persons with Parkinson’s disease.
Clinical biomechanics (Bristol, Avon). 28(1):93-7 [DOI] 10.1016/j.clinbiomech.2012.09.005. [PMID] 23062816.
2013
Lessons Learned from Open-label Deep Brain Stimulation for Tourette Syndrome: Eight Cases over 7 Years.
Tremor and other hyperkinetic movements (New York, N.Y.). 3 [DOI] 10.7916/D8M32TGM. [PMID] 24255802.
2013
Magnitude But Not Structure of Gait Variability Is Altered in Persons With Essential Tremor
Medicine and Science in Sports and Exercise. 45(5, 1)
2013
Management of deep brain stimulator battery failure: battery estimators, charge density, and importance of clinical symptoms.
PloS one. 8(3) [DOI] 10.1371/journal.pone.0058665. [PMID] 23536810.
2013
Movement disorders in 2012: Advancing research towards novel therapeutic approaches.
Nature reviews. Neurology. 9(2):70-1 [DOI] 10.1038/nrneurol.2012.265. [PMID] 23296342.
2013
Postural/Gait and cognitive function as predictors of driving performance in Parkinson’s disease.
Journal of Parkinson's disease. 3(2):153-60 [DOI] 10.3233/JPD-120152. [PMID] 23938345.
2013
Psychophysiology of Emotion in Parkinson’s Disease: From Perception To Action
Psychophysiology. 50
2013
Reliability of three Benton Judgment of Line Orientation short forms in idiopathic Parkinson’s disease.
The Clinical neuropsychologist. 27(7):1167-78 [DOI] 10.1080/13854046.2013.827744. [PMID] 23957375.
2013
Response.
Journal of neurosurgery. 119(4) [PMID] 24218650.
2013
Selective use of low frequency stimulation in Parkinson’s disease based on absence of tremor.
NeuroRehabilitation. 33(2):305-12 [DOI] 10.3233/NRE-130960. [PMID] 23949053.
2013
Shell shock: Psychogenic gait and other movement disorders-A film review.
Tremor and other hyperkinetic movements (New York, N.Y.). 3 [DOI] 10.7916/D89023HJ. [PMID] 23538744.
2013
Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
Movement disorders : official journal of the Movement Disorder Society. 28(14):1915-9 [DOI] 10.1002/mds.25735. [PMID] 24243803.
2013
Stimulation region within the globus pallidus does not affect verbal fluency performance.
Brain stimulation. 6(3):248-53 [DOI] 10.1016/j.brs.2012.05.011. [PMID] 22766102.
2013
Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review.
Parkinsonism & related disorders. 19(9):783-8 [DOI] 10.1016/j.parkreldis.2013.05.001. [PMID] 23726461.
2013
Taking a better history for behavioral issues pre- and post-deep brain stimulation: issues missed by standardized scales.
Neuromodulation : journal of the International Neuromodulation Society. 16(1):35-9; discussion 39 [DOI] 10.1111/j.1525-1403.2012.00477.x. [PMID] 22748071.
2013
The current state and needs of north american movement disorders fellowship programs.
Parkinson's disease. 2013 [DOI] 10.1155/2013/701426. [PMID] 23984186.
2013
The Demise of Poskanzer and Schwab’s Influenza Theory on the Pathogenesis of Parkinson’s Disease.
Parkinson's disease. 2013 [DOI] 10.1155/2013/167843. [PMID] 23853734.
2013
The evolving role of diffusion magnetic resonance imaging in movement disorders.
Current neurology and neuroscience reports. 13(11) [DOI] 10.1007/s11910-013-0400-1. [PMID] 24046183.
2013
The history of cerebral PET scanning: from physiology to cutting-edge technology.
Neurology. 80(10):952-6 [DOI] 10.1212/WNL.0b013e318285c135. [PMID] 23460618.
2013
The history of cerebral PET scanning: From physiology to cutting-edge technology. Author reply.
Neurology. 81(14) [DOI] 10.1212/WNL.0b013e3182aa3d3a. [PMID] 24081965.
2013
The late positive potential, emotion and apathy in Parkinson’s disease.
Neuropsychologia. 51(5):960-6 [DOI] 10.1016/j.neuropsychologia.2013.01.001. [PMID] 23320979.
2013
The temporal pattern of stimulation may be important to the mechanism of deep brain stimulation.
Experimental neurology. 247:296-302 [DOI] 10.1016/j.expneurol.2013.02.001. [PMID] 23399890.
2013
Unilateral thalamic deep brain stimulation in essential tremor demonstrates long-term ipsilateral effects.
Parkinsonism & related disorders. 19(12):1113-7 [DOI] 10.1016/j.parkreldis.2013.08.001. [PMID] 24021661.
2013
Update on treatment of essential tremor.
Current treatment options in neurology. 15(4):410-23 [DOI] 10.1007/s11940-013-0239-4. [PMID] 23881742.
2013
Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson’s disease.
Archives of physical medicine and rehabilitation. 94(7):1300-5 [DOI] 10.1016/j.apmr.2013.02.020. [PMID] 23473700.
2013
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease.
Journal of neurology. 260(2):521-7 [DOI] 10.1007/s00415-012-6669-1. [PMID] 23007193.
2013
Variability in clinical phenotypes of heterozygous and homozygous cases of Parkin-related Parkinson’s disease.
The International journal of neuroscience. 123(12):847-9 [DOI] 10.3109/00207454.2013.810626. [PMID] 23767969.
2012
[The transition of deep brain stimulation from disease specific to symptom specific indications].
Rinsho shinkeigaku = Clinical neurology. 52(11):891-5 [PMID] 23196455.
2012
A Three-dimensional Deformable Brain Atlas for DBS Targeting. I. Methodology for Atlas Creation and Artifact Reduction.
The open neuroimaging journal. 6:92-8 [DOI] 10.2174/1874440001206010092. [PMID] 23091579.
2012
Addiction-like manifestations and Parkinson’s disease: a large single center 9-year experience.
The International journal of neuroscience. 122(3):145-53 [DOI] 10.3109/00207454.2011.633722. [PMID] 22023411.
2012
Amantadine: the journey from fighting flu to treating Parkinson disease.
Neurology. 78(14):1096-9 [DOI] 10.1212/WNL.0b013e31824e8f0d. [PMID] 22474298.
2012
Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson’s disease?
The Journal of neuropsychiatry and clinical neurosciences. 24(3):326-30 [DOI] 10.1176/appi.neuropsych.11090210. [PMID] 23037646.
2012
Bone mineral density (BMD) in male patients with Parkinson’s disease.
The International journal of neuroscience. 122(9):523-7 [DOI] 10.3109/00207454.2012.685530. [PMID] 22510054.
2012
Carbidopa/levodopa dose elevation and safety concerns in Parkinson’s patients: a cross-sectional and cohort design.
BMJ open. 2(6) [DOI] 10.1136/bmjopen-2012-001971. [PMID] 23233700.
2012
Clinical and Demographic Correlates of Antidepressant Utilisation in Parkinson’S Disease Population
. 78
2012
Components of depression in Parkinson disease.
Journal of geriatric psychiatry and neurology. 25(3):131-7 [DOI] 10.1177/0891988712455236. [PMID] 22859701.
2012
DBS and electrical neuro-network modulation to treat neurological disorders.
International review of neurobiology. 107:253-82 [DOI] 10.1016/B978-0-12-404706-8.00014-0. [PMID] 23206686.
2012
Deep brain stimulation and the role of astrocytes.
Molecular psychiatry. 17(2):124-31, 115 [DOI] 10.1038/mp.2011.61. [PMID] 21625231.
2012
Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy.
Parkinsonism & related disorders. 18(1):86-8 [DOI] 10.1016/j.parkreldis.2011.09.008. [PMID] 21983018.
2012
Deep-brain stimulation for Parkinson’s disease.
The New England journal of medicine. 367(16):1529-38 [DOI] 10.1056/NEJMct1208070. [PMID] 23075179.
2012
Depressive Symptoms in Parkinson Disease as Measured By Beck’S Depression Scale and Its Relationship To Visual Analogue Mood Scale, Motor Symptoms and the Quality of Life Measures
. 78
2012
Dimensions of apathy in Parkinson’s disease: exploratory factor analysis of the apathy scale.
Journal of Parkinson's disease. 2(2):161-6 [DOI] 10.3233/JPD-2012-12085. [PMID] 23939440.
2012
Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.
PloS one. 7(1) [DOI] 10.1371/journal.pone.0029768. [PMID] 22295068.
2012
Emerging opportunities for serotypes of botulinum neurotoxins.
Toxins. 4(11):1196-222 [DOI] 10.3390/toxins4111196. [PMID] 23202312.
2012
Encephalopathy, hypoglycemia, and flailing extremities: a case of bilateral chorea-ballism associated with diabetic ketoacidosis.
Tremor and other hyperkinetic movements (New York, N.Y.). 2 [DOI] 10.7916/D8RX99T2. [PMID] 23439397.
2012
Factors Predicting Improvement in Essential Head Tremor Following Deep Brain Stimulation
. 78
2012
Fatigue, Sleepiness and Sleep Issues in Patients With Dystonia
. 78
2012
GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease.
Parkinsonism & related disorders. 18(7):814-8 [DOI] 10.1016/j.parkreldis.2012.03.022. [PMID] 22525365.
2012
Health comorbidities and cognition in 1948 patients with idiopathic Parkinson’s disease.
Parkinsonism & related disorders. 18(10):1073-8 [DOI] 10.1016/j.parkreldis.2012.06.004. [PMID] 22776043.
2012
Improvement of both dystonia and tics with 60 Hz pallidal deep brain stimulation.
The International journal of neuroscience. 122(9):519-22 [DOI] 10.3109/00207454.2012.683219. [PMID] 22494180.
2012
Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette’s syndrome.
PloS one. 7(9) [DOI] 10.1371/journal.pone.0044215. [PMID] 22970181.
2012
Low-Frequency Deep Brain Stimulation for Dystonia: Lower is Not Always Better.
Tremor and other hyperkinetic movements (New York, N.Y.). 2 [DOI] 10.7916/D85X27PH. [PMID] 23450104.
2012
Micrographia and related deficits in Parkinson’s disease: a cross-sectional study.
BMJ open. 2(3) [DOI] 10.1136/bmjopen-2011-000628. [PMID] 22734114.
2012
Mood and motor trajectories in Parkinson’s disease: Multivariate latent growth curve modeling.
Neuropsychology. 26(1):71-80 [DOI] 10.1037/a0025119. [PMID] 22142359.
2012
Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains.
Brain research. 1464:61-72 [DOI] 10.1016/j.brainres.2012.04.039. [PMID] 22652067.
2012
Parkinson’S Study Group Neurosurgical Working Group (Psg-Nswg) Deep Brain Stimulation (Dbs) Non-Motor Symptoms (Nms) Survey: Perceived Patient and Treatment Team Outcomes
Movement Disorders. 27
2012
Personalized Medicine in Deep Brain Stimulation Through Utilization of Neural Oscillations
. 78:1900-1901
2012
Personalized medicine in deep brain stimulation through utilization of neural oscillations.
Neurology. 78(24):1900-1 [DOI] 10.1212/WNL.0b013e318259e2af. [PMID] 22592364.
2012
Postmortem observation of collagenous lead tip region fibrosis as a rare complication of DBS.
Movement disorders : official journal of the Movement Disorder Society. 27(4):565-9 [DOI] 10.1002/mds.24916. [PMID] 22314706.
2012
Quantitative normative gait data in a large cohort of ambulatory persons with Parkinson’s disease.
PloS one. 7(8) [DOI] 10.1371/journal.pone.0042337. [PMID] 22879945.
2012
Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issues.
Brain stimulation. 5(4):599-604 [DOI] 10.1016/j.brs.2011.10.004. [PMID] 22305344.
2012
Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.
Neuromodulation : journal of the International Neuromodulation Society. 15(3):246-50; discussion 250 [DOI] 10.1111/j.1525-1403.2012.00437.x. [PMID] 22376158.
2012
Setting realistic expectations for DBS in dystonia.
The Lancet. Neurology. 11(12):1014-5 [DOI] 10.1016/S1474-4422(12)70263-6. [PMID] 23123072.
2012
Stem cell pathologies and neurological disease.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 25(2):157-62 [DOI] 10.1038/modpathol.2011.165. [PMID] 22056951.
2012
Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial.
The Lancet. Neurology. 11(2):140-9 [DOI] 10.1016/S1474-4422(11)70308-8. [PMID] 22239915.
2012
Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor.
Tremor and other hyperkinetic movements (New York, N.Y.). 2 [DOI] 10.7916/D8ZG6QZ2. [PMID] 23440408.
2012
The emerging field of palliative care for Parkinson’s disease. Letter from the guest editors.
Parkinsonism & related disorders. 18 Suppl 3 [DOI] 10.1016/j.parkreldis.2012.10.012. [PMID] 23206368.
2012
The prevalence of fatigue following deep brain stimulation surgery in Parkinson’s disease and association with quality of life.
Parkinson's disease. 2012 [DOI] 10.1155/2012/769506. [PMID] 22666631.
2012
Toys and gadgets: construct validity of apathy in Parkinson’s disease.
The Journal of neuropsychiatry and clinical neurosciences. 24(4):463-71 [DOI] 10.1176/appi.neuropsych.11080195. [PMID] 23224453.
2012
Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.
Neurology. 78(9):649-57 [DOI] 10.1212/WNL.0b013e3182494d51. [PMID] 22345219.
2012
What are the issues facing Parkinson’s disease patients at ten years of disease and beyond? Data from the NPF-QII study.
Parkinsonism & related disorders. 18 Suppl 3:S10-4 [DOI] 10.1016/j.parkreldis.2012.06.014. [PMID] 22776044.
2012
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Brain : a journal of neurology. 135(Pt 5):1455-62 [DOI] 10.1093/brain/aws026. [PMID] 22344584.
2011
A pilot study of human brain tissue post-magnetic resonance imaging: information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN).
NeuroImage. 54 Suppl 1:S233-7 [DOI] 10.1016/j.neuroimage.2010.09.014. [PMID] 20849960.
2011
Alternate but do not swim: a test for executive motor dysfunction in Parkinson disease.
Journal of the International Neuropsychological Society : JINS. 17(4):702-8 [DOI] 10.1017/S1355617711000609. [PMID] 22882811.
2011
Antiphospholipid syndrome and other lupus-related movement disorders.
Handbook of clinical neurology. 100:237-45 [DOI] 10.1016/B978-0-444-52014-2.00016-1. [PMID] 21496583.
2011
Apathy and depression: separate factors in Parkinson’s disease.
Journal of the International Neuropsychological Society : JINS. 17(6):1058-66 [DOI] 10.1017/S1355617711001068. [PMID] 22040900.
2011
Binge eating in Parkinson’s disease: prevalence, correlates and the contribution of deep brain stimulation.
The Journal of neuropsychiatry and clinical neurosciences. 23(1):56-62 [PMID] 21304139.
2011
Clock drawing in the Montreal Cognitive Assessment: recommendations for dementia assessment.
Dementia and geriatric cognitive disorders. 31(3):179-87 [DOI] 10.1159/000324639. [PMID] 21389719.
2011
Collagenous Fibrosis: a Rare Tissue Reaction of Deep Brain Stimulation (Dbs)
Journal of Neuropathology and Experimental Neurology. 70
2011
DBS candidates that fall short on a levodopa challenge test: alternative and important indications.
The neurologist. 17(5):263-8 [DOI] 10.1097/NRL.0b013e31822d1069. [PMID] 21881468.
2011
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.
Archives of neurology. 68(2) [DOI] 10.1001/archneurol.2010.260. [PMID] 20937936.
2011
Delayed clinical improvement after deep brain stimulation-related subdural hematoma. Report of 4 cases.
Journal of neurosurgery. 115(2):289-94 [DOI] 10.3171/2011.3.JNS101424. [PMID] 21476805.
2011
Detecting Emotional Significance: the Late Positive Potential in Parkinson’S Disease
Psychophysiology. 48
2011
Did General Douglas Macarthur Have Parkinson Disease? a Video and Archival Analysis
. 76:1668-1672
2011
Did General Douglas MacArthur have Parkinson disease? A video and archival analysis.
Neurology. 76(19):1668-72 [DOI] 10.1212/WNL.0b013e318219fb18. [PMID] 21555736.
2011
Do patient’s get angrier following STN, GPi, and thalamic deep brain stimulation.
NeuroImage. 54 Suppl 1:S227-32 [DOI] 10.1016/j.neuroimage.2010.09.077. [PMID] 20932923.
2011
Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease?
Neurosurgery. 69(2):357-60; discussion 360 [DOI] 10.1227/NEU.0b013e3182160456. [PMID] 21415789.
2011
Dr. Henry Head and lessons learned from his self-experiment on radial nerve transection.
Journal of neurosurgery. 114(2):529-33 [DOI] 10.3171/2010.8.JNS10400. [PMID] 20932092.
2011
Effect of Deep Brain Stimulation on Parkinson’s Nonmotor Symptoms following Unilateral DBS: A Pilot Study.
Parkinson's disease. 2011 [DOI] 10.4061/2011/507416. [PMID] 22220288.
2011
Emotion and ocular responses in Parkinson’s disease.
Neuropsychologia. 49(12):3247-53 [DOI] 10.1016/j.neuropsychologia.2011.07.029. [PMID] 21839756.
2011
Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.
Neurology. 77(19):1752-5 [DOI] 10.1212/WNL.0b013e318236f0fd. [PMID] 22013182.
2011
Generic versus branded pharmacotherapy in Parkinson’s disease: does it matter? A review.
Parkinsonism & related disorders. 17(5):308-12 [DOI] 10.1016/j.parkreldis.2011.02.005. [PMID] 21367644.
2011
Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers.
Parkinsonism & related disorders. 17(6):440-5 [DOI] 10.1016/j.parkreldis.2011.03.002. [PMID] 21458353.
2011
It is time to remove the ‘benign’ from the essential tremor label.
Parkinsonism & related disorders. 17(7):516-20 [DOI] 10.1016/j.parkreldis.2011.03.012. [PMID] 21486707.
2011
Lateral ventricle volume is poor predictor of post unilateral DBS motor change for Parkinson’s disease.
Parkinsonism & related disorders. 17(5):343-7 [DOI] 10.1016/j.parkreldis.2011.01.018. [PMID] 21345713.
2011
Lessons learned from a large single center cohort of patients referred for DBS management.
Parkinsonism & related disorders. 17(4):236-9 [DOI] 10.1016/j.parkreldis.2010.05.003. [PMID] 20627660.
2011
Management of the hospitalized patient with Parkinson’s disease: current state of the field and need for guidelines.
Parkinsonism & related disorders. 17(3):139-45 [DOI] 10.1016/j.parkreldis.2010.11.009. [PMID] 21159538.
2011
Measurement of patient-centered outcomes in Parkinson’s disease: what do patients really want from their treatment?
Parkinsonism & related disorders. 17(2):89-94 [DOI] 10.1016/j.parkreldis.2010.09.005. [PMID] 20952243.
2011
Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms.
Journal of neurology. 258(11):2069-74 [DOI] 10.1007/s00415-011-6075-0. [PMID] 21553081.
2011
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
NeuroImage. 54 Suppl 1(Suppl 1):S106-24 [DOI] 10.1016/j.neuroimage.2010.01.105. [PMID] 20149882.
2011
Nonmotor manifestations of dystonia: a systematic review.
Movement disorders : official journal of the Movement Disorder Society. 26(7):1206-17 [DOI] 10.1002/mds.23709. [PMID] 21484874.
2011
Parkinson disease: Improving quality of care in Parkinson disease.
Nature reviews. Neurology. 7(4):196-7 [DOI] 10.1038/nrneurol.2011.38. [PMID] 21403671.
2011
Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome.
Tremor and other hyperkinetic movements (New York, N.Y.). 1 [DOI] 10.7916/D8XG9PWK. [PMID] 23440654.
2011
Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency.
NeuroImage. 54 Suppl 1:S238-46 [DOI] 10.1016/j.neuroimage.2010.03.068. [PMID] 20362061.
2011
Pilot Study On the Effects of Poor Sleep On Executive Functioning in Essential Tremor and Parkinson’s Disease
Sleep. 34
2011
Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.
The Clinical neuropsychologist. 25(1):141-59 [DOI] 10.1080/13854046.2010.532812. [PMID] 21253963.
2011
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy.
Parkinsonism & related disorders. 17(6):451-5 [DOI] 10.1016/j.parkreldis.2011.03.009. [PMID] 21482169.
2011
Respiratory-swallowing coordination and swallowing safety in patients with Parkinson’s disease.
Dysphagia. 26(3):218-24 [DOI] 10.1007/s00455-010-9289-x. [PMID] 20623304.
2011
Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder.
NeuroImage. 54 Suppl 1:S247-55 [DOI] 10.1016/j.neuroimage.2010.03.009. [PMID] 20226259.
2011
Steady or not following thalamic deep brain stimulation for essential tremor.
Journal of neurology. 258(9):1643-8 [DOI] 10.1007/s00415-011-5986-0. [PMID] 21442464.
2011
The case for testing memory with both stories and word lists prior to dbs surgery for Parkinson’s Disease.
The Clinical neuropsychologist. 25(3):348-58 [DOI] 10.1080/13854046.2011.562869. [PMID] 21491347.
2011
The distal partial trisomy 1q syndrome and dystonic tremor.
Parkinsonism & related disorders. 17(2):128-9 [DOI] 10.1016/j.parkreldis.2010.10.004. [PMID] 21044857.
2011
The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.
Parkinson's disease. 2011 [DOI] 10.4061/2011/290195. [PMID] 21808724.
2011
The national DBS brain tissue network pilot study: need for more tissue and more standardization.
Cell and tissue banking. 12(3):219-31 [DOI] 10.1007/s10561-010-9189-1. [PMID] 20589432.
2011
The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson’s disease.
Parkinsonism & related disorders. 17(3):182-8 [DOI] 10.1016/j.parkreldis.2010.12.011. [PMID] 21256069.
2011
Unilateral deep brain stimulation surgery in Parkinson’s disease improves ipsilateral symptoms regardless of laterality.
Parkinsonism & related disorders. 17(10):745-8 [DOI] 10.1016/j.parkreldis.2011.07.010. [PMID] 21856205.
2011
Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease.
The neurologist. 17(5):282-5 [DOI] 10.1097/NRL.0b013e318217367b. [PMID] 21881473.
2011
Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease.
The American journal of occupational therapy : official publication of the American Occupational Therapy Association. 65(5):579-88 [PMID] 22026326.
2011
Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.
Neurosurgery. 68(5):1233-7; discussion 1237 [DOI] 10.1227/NEU.0b013e31820b52c5. [PMID] 21273927.
2010
A case of mania following deep brain stimulation for obsessive compulsive disorder.
Stereotactic and functional neurosurgery. 88(5):322-8 [DOI] 10.1159/000319960. [PMID] 20714212.
2010
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort.
Journal of neurosurgery. 113(6):1224-9 [DOI] 10.3171/2010.8.JNS10312. [PMID] 20849215.
2010
An evaluation of rating scales utilized for deep brain stimulation for dystonia.
Journal of neurology. 257(1):44-58 [DOI] 10.1007/s00415-009-5261-9. [PMID] 19639382.
2010
Are Results From Pd Trials Generalizable? the Npf Database Reveals a Mismatch Between Typical Clinic Populations and Subjects in Pd Trials
Movement Disorders. 25
2010
Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial.
Neurology. 75(21):1912-9 [DOI] 10.1212/WNL.0b013e3181fef115. [PMID] 21098406.
2010
Attentional Resource Allocation and Swallow Function in Parkinson’s Disease
Dysphagia. 25
2010
Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor.
Journal of neurosurgery. 112(3):491-6 [DOI] 10.3171/2009.7.JNS09150. [PMID] 19663554.
2010
Can exercise improve language and cognition in Parkinson’s disease? A case report.
Neurocase. 16(4):301-6 [DOI] 10.1080/13554790903559663. [PMID] 20391181.
2010
Clonazepam and botulinum toxin for the treatment of alien limb phenomenon.
The neurologist. 16(2):106-8 [DOI] 10.1097/NRL.0b013e3181a0d670. [PMID] 20220444.
2010
Cognitive declines after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using Reliable Change, part II.
The Clinical neuropsychologist. 24(2):235-45 [DOI] 10.1080/13854040903277297. [PMID] 19953428.
2010
Converting the UPDRS part III to the Hoehn and Yahr staging may not be adequate for a research database.
Parkinsonism & related disorders. 16(2):150; author reply 151-2 [DOI] 10.1016/j.parkreldis.2009.10.002. [PMID] 19836290.
2010
Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design.
Biological psychiatry. 67(6):535-42 [DOI] 10.1016/j.biopsych.2009.11.028. [PMID] 20116047.
2010
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.
Molecular psychiatry. 15(1):64-79 [DOI] 10.1038/mp.2008.55. [PMID] 18490925.
2010
Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag).
Stereotactic and functional neurosurgery. 88(5):329-33 [DOI] 10.1159/000319961. [PMID] 20714213.
2010
Disrupting abnormal electrical activity with deep brain stimulation: is epilepsy the next frontier?
Neurosurgical focus. 29(2) [DOI] 10.3171/2010.4.FOCUS10104. [PMID] 20672924.
2010
Elementary, my dear Dr. Allen: the case of barium toxicity and Pa Ping.
Neurology. 74(19):1546-9 [DOI] 10.1212/WNL.0b013e3181e222ee. [PMID] 20458073.
2010
Factors related to extended hospital stays following deep brain stimulation for Parkinson’s disease.
Parkinsonism & related disorders. 16(5):324-8 [DOI] 10.1016/j.parkreldis.2010.02.002. [PMID] 20202888.
2010
Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies.
Parkinsonism & related disorders. 16(3):153-62 [DOI] 10.1016/j.parkreldis.2009.10.003. [PMID] 19896407.
2010
INPH and Parkinson disease: differentiation by levodopa response.
Nature reviews. Neurology. 6(1):52-6 [DOI] 10.1038/nrneurol.2009.195. [PMID] 20057498.
2010
Is rhinorrhea an under-recognized intrinsic symptom of Parkinson disease? A prospective pilot study.
The International journal of neuroscience. 120(4):258-60 [DOI] 10.3109/00207451003615755. [PMID] 20374072.
2010
Knee extensor strength, dynamic stability, and functional ambulation: are they related in Parkinson’s disease?
Archives of physical medicine and rehabilitation. 91(4):589-95 [DOI] 10.1016/j.apmr.2009.11.026. [PMID] 20382292.
2010
Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder.
Neurocase. 16(4):321-30 [DOI] 10.1080/13554790903560422. [PMID] 20178034.
2010
Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor.
European journal of neurology. 17(8):1040-6 [DOI] 10.1111/j.1468-1331.2010.02958.x. [PMID] 20113336.
2010
Osteoporosis and Osteopenia in Both Early and Late Parkinson’s Disease in Men.
Endocrine Reviews. 31
2010
Parkinson Patients Care About Improving Their Sleep Difficulties: Do We Care?
Sleep. 33
2010
Parkinson’s disease in women: a call for improved clinical studies and for comparative effectiveness research.
Maturitas. 65(4):352-8 [DOI] 10.1016/j.maturitas.2010.01.001. [PMID] 20117891.
2010
Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries.
Parkinsonism & related disorders. 16(9):566-71 [DOI] 10.1016/j.parkreldis.2010.06.012. [PMID] 20650672.
2010
Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets.
Expert review of neurotherapeutics. 10(12):1847-57 [PMID] 21384698.
2010
Piloting the NPF data-driven quality improvement initiative.
Parkinsonism & related disorders. 16(8):517-21 [DOI] 10.1016/j.parkreldis.2010.06.005. [PMID] 20609611.
2010
Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida.
International journal of geriatric psychiatry. 25(5):540-1 [DOI] 10.1002/gps.2324. [PMID] 20391589.
2010
Prevalence of Twiddler’s syndrome as a cause of deep brain stimulation hardware failure.
Stereotactic and functional neurosurgery. 88(6):353-9 [DOI] 10.1159/000319039. [PMID] 20861658.
2010
Pseudobulbar affect: prevalence and quality of life impact in movement disorders.
Journal of neurology. 257(8):1382-7 [DOI] 10.1007/s00415-010-5550-3. [PMID] 20376475.
2010
Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes.
Neurosurgical focus. 29(2) [DOI] 10.3171/2010.4.FOCUS10100. [PMID] 20672921.
2010
Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 25(7):961-2; author reply 962 [DOI] 10.1002/mds.23021. [PMID] 20461816.
2010
Should we consider Vim thalamic deep brain stimulation for select cases of severe refractory dystonic tremor.
Stereotactic and functional neurosurgery. 88(2):98-104 [DOI] 10.1159/000289354. [PMID] 20197711.
2010
Speech motor program maintenance, but not switching, is enhanced by left-hemispheric deep brain stimulation in Parkinson’s disease.
International journal of speech-language pathology. 12(5):385-98 [DOI] 10.3109/17549507.2010.491870. [PMID] 20586527.
2010
Surgical Treatment of Levodopa-Related Dyskinesias
Movement Disorders. 25
2010
Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson’s disease.
Parkinsonism & related disorders. 16(9):590-4 [DOI] 10.1016/j.parkreldis.2010.08.008. [PMID] 20829093.
2010
The effect of deep brain stimulation surgery on repetitive behavior in Parkinson patients: A case series.
Neurocase. 16(1):31-6 [DOI] 10.1080/13554790903193190. [PMID] 20391184.
2010
The impact of and the factors associated with drooling in Parkinson’s disease.
Parkinsonism & related disorders. 16(7):475-7 [DOI] 10.1016/j.parkreldis.2009.12.003. [PMID] 20064737.
2010
The number and nature of emergency department encounters in patients with deep brain stimulators.
Journal of neurology. 257(1):122-31 [DOI] 10.1007/s00415-009-5343-8. [PMID] 19813069.
2010
The Pupil as a Measure of Emotion-Modulated Arousal in Parkinson’s Disease
Psychophysiology. 47
2010
The relationship between anosmia, constipation, and orthostasis and Parkinson’s disease duration: results of a pilot study.
The International journal of neuroscience. 120(1):67-70 [DOI] 10.3109/00207450903337721. [PMID] 20128674.
2010
Time for comprehensive care networks for Parkinson’s disease.
The Lancet. Neurology. 9(1):20-2 [DOI] 10.1016/S1474-4422(09)70331-X. [PMID] 19959399.
2010
Update on deep brain stimulation for neuropsychiatric disorders.
Neurobiology of disease. 38(3):346-53 [DOI] 10.1016/j.nbd.2010.01.011. [PMID] 20096357.
2010
Using voluntary cough to detect penetration and aspiration during oropharyngeal swallowing in patients with Parkinson disease.
Chest. 138(6):1426-31 [DOI] 10.1378/chest.10-0342. [PMID] 20705802.
2009
A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR).
NeuroImage. 47 Suppl 2:T44-52 [DOI] 10.1016/j.neuroimage.2009.04.018. [PMID] 19362595.
2009
A Small Pilot Study of Smile Induction in the Nih Ocd Dbs Cohort: a Potential Predictor of Therapy Response?
Annals of Neurology. 66:S78-S79
2009
Artistic creativity and DBS: a case report.
Journal of the neurological sciences. 276(1-2):138-42 [DOI] 10.1016/j.jns.2008.09.021. [PMID] 18945449.
2009
Awareness of expressivity deficits in non-demented Parkinson disease.
The Clinical neuropsychologist. 23(5):805-17 [DOI] 10.1080/13854040802572434. [PMID] 19169938.
2009
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
Journal of neurology, neurosurgery, and psychiatry. 80(7):794-7 [DOI] 10.1136/jnnp.2008.159558. [PMID] 19237386.
2009
Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
Annals of neurology. 65(5):586-95 [DOI] 10.1002/ana.21596. [PMID] 19288469.
2009
Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson’s disease: a controlled study using reliable change.
The Clinical neuropsychologist. 23(3):385-405 [DOI] 10.1080/13854040802360582. [PMID] 18821180.
2009
De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report.
Journal of neurology. 256(9):1533-9 [DOI] 10.1007/s00415-009-5159-6. [PMID] 19437063.
2009
Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
Journal of geriatric psychiatry and neurology. 22(4):223-7 [DOI] 10.1177/0891988709335792. [PMID] 19429848.
2009
Does laterality of motor impairment tell us something about cognition in Parkinson disease?
Parkinsonism & related disorders. 15(4):315-7 [DOI] 10.1016/j.parkreldis.2008.07.009. [PMID] 18793864.
2009
Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control.
Journal of neurology. 256(12):2030-5 [DOI] 10.1007/s00415-009-5235-y. [PMID] 19597692.
2009
Enough is enough: moving on to deep brain stimulation in patients with fluctuating Parkinson disease.
Archives of neurology. 66(6):778-80 [DOI] 10.1001/archneurol.2009.82. [PMID] 19506140.
2009
Examination of the Lille Apathy Rating Scale in Parkinson disease.
Movement disorders : official journal of the Movement Disorder Society. 24(5):677-83 [DOI] 10.1002/mds.22441. [PMID] 19133658.
2009
Failed DBS for palliation of visual problems in a case of oculopalatal tremor.
Parkinsonism & related disorders. 15(1):71-3 [DOI] 10.1016/j.parkreldis.2008.01.020. [PMID] 18395484.
2009
Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinson’s Disease
. 9:375-388
2009
Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson’s disease.
Current gene therapy. 9(5):375-88 [PMID] 19860652.
2009
Genome-wide association study reveals genetic risk underlying Parkinson’s disease.
Nature genetics. 41(12):1308-12 [DOI] 10.1038/ng.487. [PMID] 19915575.
2009
Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.
Journal of neurology. 256(8):1321-9 [DOI] 10.1007/s00415-009-5121-7. [PMID] 19363633.
2009
How cautious should we be when assessing apathy with the Unified Parkinson’s Disease Rating Scale?
Movement disorders : official journal of the Movement Disorder Society. 24(5):684-8 [DOI] 10.1002/mds.22437. [PMID] 19185011.
2009
Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease.
Chest. 135(5):1301-1308 [DOI] 10.1378/chest.08-1389. [PMID] 19029430.
2009
Inappropriate crying and laughing in Parkinson disease and movement disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 10(3):234-40 [DOI] 10.1080/15622970701639445. [PMID] 18609421.
2009
Is the n-back task a valid neuropsychological measure for assessing working memory?
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 24(7):711-7 [DOI] 10.1093/arclin/acp063. [PMID] 19767297.
2009
Mood and energy determinants of quality of life in dystonia.
Journal of neurology. 256(6):996-1001 [DOI] 10.1007/s00415-009-5060-3. [PMID] 19277765.
2009
Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.
The Clinical neuropsychologist. 23(1):100-17 [DOI] 10.1080/13854040801894714. [PMID] 18609312.
2009
Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems.
NeuroRehabilitation. 24(2):131-44 [DOI] 10.3233/NRE-2009-0462. [PMID] 19339752.
2009
Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use.
International journal of general medicine. 2:57-61 [PMID] 20360887.
2009
Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
The International journal of neuroscience. 119(12):2196-205 [DOI] 10.3109/00207450903222758. [PMID] 19916848.
2009
Safety of MRI in patients with implanted deep brain stimulation devices.
NeuroImage. 47 Suppl 2:T53-7 [DOI] 10.1016/j.neuroimage.2009.04.044. [PMID] 19376247.
2009
Side onset influences motor impairments in Parkinson disease.
Parkinsonism & related disorders. 15(10):781-3 [DOI] 10.1016/j.parkreldis.2009.02.001. [PMID] 19447063.
2009
SNCA variants are associated with increased risk for multiple system atrophy.
Annals of neurology. 65(5):610-4 [DOI] 10.1002/ana.21685. [PMID] 19475667.
2009
Startle reflex hyporeactivity in Parkinson’s disease: an emotion-specific or arousal-modulated deficit?
Neuropsychologia. 47(8-9):1917-27 [DOI] 10.1016/j.neuropsychologia.2009.03.002. [PMID] 19428424.
2009
Subjective perception of cognition is related to mood and not performance.
Epilepsy & behavior : E&B. 14(3):459-64 [DOI] 10.1016/j.yebeh.2008.12.007. [PMID] 19130899.
2009
Surgical treatment of movement disorders.
Neurologic clinics. 27(3):633-77, v [DOI] 10.1016/j.ncl.2009.04.006. [PMID] 19555825.
2009
Swallow Outcomes Following Intervention With Expiratory Muscle Strength Training (Emst) in Parkinson’s Disease: Results of a Randomized Clinical Trial
Dysphagia. 24:455-456
2009
The Relationship Between Quality of Life and Swallowing in Parkinson’s Disease
Dysphagia. 24:464-465
2009
The relationship between quality of life and swallowing in Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 24(9):1352-8 [DOI] 10.1002/mds.22617. [PMID] 19425089.
2009
Tracing the origin of L-2-hydroxyglutaric aciduria in a family.
The International journal of neuroscience. 119(11):2118-23 [PMID] 19863265.
2009
Turning off artistic ability: the influence of left DBS in art production.
Journal of the neurological sciences. 281(1-2):116-21 [DOI] 10.1016/j.jns.2009.03.001. [PMID] 19329128.
2009
Useful field of view as a reliable screening measure of driving performance in people with Parkinson’s disease: results of a pilot study.
Traffic injury prevention. 10(6):593-8 [DOI] 10.1080/15389580903179901. [PMID] 19916131.
2009
Venous air embolism in deep brain stimulation.
Stereotactic and functional neurosurgery. 87(1):25-30 [DOI] 10.1159/000177625. [PMID] 19039260.
2009
Will Tricyclic Antidepressants Make a Comeback for Depressed Parkinson Disease Patients?
. 72:868-869
2008
A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders.
Parkinsonism & related disorders. 14(7):532-8 [DOI] 10.1016/j.parkreldis.2008.01.001. [PMID] 18325819.
2008
A Clinical Review of Deep Brain Stimulation and Its Effects On Limbic Basal Ganglia Circuitry
. 13:5708-5731
2008
Albert Sidney Johnston’s sciatic dueling injury did not contribute to his death at the Battle of Shiloh.
Neurosurgery. 63(6):1192-7; discussion 1197 [DOI] 10.1227/01.NEU.0000327687.45271.45. [PMID] 19057333.
2008
Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease.
Experimental neurology. 214(1):1-5 [DOI] 10.1016/j.expneurol.2008.07.019. [PMID] 18718469.
2008
Avoiding deep brain stimulation failures in Tourette syndrome.
Journal of neurology, neurosurgery, and psychiatry. 79(2):111-2 [DOI] 10.1136/jnnp.2007.135715. [PMID] 18202200.
2008
Clinical cases where lesion therapy was chosen over deep brain stimulation.
Stereotactic and functional neurosurgery. 86(3):147-52 [DOI] 10.1159/000120426. [PMID] 18334856.
2008
Clinical review of deep brain stimulation and its effects on limbic basal ganglia circuitry.
Frontiers in bioscience : a journal and virtual library. 13:5708-31 [PMID] 18508617.
2008
Cognitive Declines One Year After Unilateral Stn and Gpi Deep Brain Stimulation Surgery in Parkinson’S Disease
Movement Disorders. 23
2008
Compulsive Behaviors Ii: Compulsive Behaviors Versus Impulse Control Disorders: a Single-Center Experience From the University of Florida Movement Disorders Center
Movement Disorders. 23:1335-1336
2008
Declines in Memory and Processing Speed After Deep Brain Stimulation Surgery for Parkinson Disease
Movement Disorders. 23
2008
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations.
Movement disorders : official journal of the Movement Disorder Society. 23(16):2357-62 [DOI] 10.1002/mds.22271. [PMID] 18759339.
2008
Deep brain stimulation: treating neurological and psychiatric disorders by modulating brain activity.
NeuroRehabilitation. 23(1):105-13 [PMID] 18356594.
2008
Distribution of motor impairment influences quality of life in Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 23(10):1466-8 [DOI] 10.1002/mds.22162. [PMID] 18546324.
2008
Intact Global Cognition On the Drs-2 in Parkinson Disease May Be Misleading
Movement Disorders. 23
2008
Pushing or pulling to predict falls in Parkinson disease?
Nature clinical practice. Neurology. 4(10):530-1 [DOI] 10.1038/ncpneuro0912. [PMID] 18797438.
2008
Reoperation for suboptimal outcomes after deep brain stimulation surgery.
Neurosurgery. 63(4):754-60; discussion 760 [DOI] 10.1227/01.NEU.0000325492.58799.35. [PMID] 18981887.
2008
Role of Dopaminergic Medications in Influencing Masked Facies in Pd: Timing Is Key
Movement Disorders. 23
2008
Tardive parkinsonism in a bipolar patient: post-mortem examination supports a physiological rather than pathological dysfunction.
Neurocase. 15(1):66-9 [DOI] 10.1080/13554790802613033. [PMID] 19235627.
2008
The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson’s patients.
Parkinsonism & related disorders. 14(6):481-8 [DOI] 10.1016/j.parkreldis.2007.11.014. [PMID] 18342565.
2007
Abnormal affective startle modulation in individuals with psychogenic [corrected] movement disorder.
Movement disorders : official journal of the Movement Disorder Society. 22(9):1265-71 [PMID] 17486611.
2007
BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson’s disease in diverse ethnic groups.
Neuroscience letters. 415(1):59-63 [PMID] 17229524.
2007
Cognitive decline tracks motor progression and not disease duration in Parkinson patients.
Neuropsychiatric disease and treatment. 3(6):955-8 [PMID] 19300633.
2007
Comprehensive screening of a North American Parkinson’s disease cohort for LRRK2 mutation.
Neuro-degenerative diseases. 4(5):386-91 [PMID] 17622782.
2007
Deep brain stimulation and the role of the neuropsychologist.
The Clinical neuropsychologist. 21(1):162-89 [PMID] 17366283.
2007
Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming.
Journal of neurology, neurosurgery, and psychiatry. 78(3):310-4 [PMID] 17012341.
2007
Depression symptoms in movement disorders: comparing Parkinson’s disease, dystonia, and essential tremor.
Movement disorders : official journal of the Movement Disorder Society. 22(5):666-72 [PMID] 17266084.
2007
Identifying candidates for deep brain stimulation in Parkinson’s disease: the role of the primary care physician.
Geriatrics. 62(5):18-24 [PMID] 17489644.
2007
Is decreased dexterity in Parkinson disease due to apraxia?
Neurology. 68(23):2044; author reply 2044-5 [PMID] 17548559.
2007
Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 22(1):141-5 [PMID] 17089386.
2007
Limb-kinetic apraxia in Parkinson disease.
Neurology. 68(2):150-1 [PMID] 17151340.
2007
Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.
Current neurology and neuroscience reports. 7(4):278-89 [PMID] 17618533.
2007
Paul Blocq and (psychogenic) astasia abasia.
Movement disorders : official journal of the Movement Disorder Society. 22(10):1373-1378 [DOI] 10.1002/mds.21474. [PMID] 17516452.
2007
Pearls in patient selection for deep brain stimulation.
The neurologist. 13(5):253-60 [PMID] 17848865.
2007
Punding as a complication of brain stem stroke?: report of a case.
Stroke. 38(4):1390-2 [PMID] 17332454.
2007
Role of deep brain stimulation targeted to the pedunculopontine nucleus in Parkinson’s disease.
Expert review of neurotherapeutics. 7(6):585-9 [PMID] 17563240.
2007
The “chair test” to aid in the diagnosis of psychogenic gait disorders.
The neurologist. 13(2):87-91 [PMID] 17351529.
2007
The crossed response inhibition task in Parkinson’s disease: disinhibition hyperkinesia.
Neurocase. 13(3):158-64 [PMID] 17786774.
2007
The four As associated with pathological Parkinson disease gamblers: anxiety, anger, age, and agonists.
Neuropsychiatric disease and treatment. 3(1):161-7 [PMID] 19300546.
2006
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia.
Archives of neurology. 63(8):1181-4 [PMID] 16908749.
2006
Dissociating apathy and depression in Parkinson disease.
Neurology. 67(1):33-8 [PMID] 16832074.
2006
Dual electrode thalamic deep brain stimulation for the treatment of posttraumatic and multiple sclerosis tremor.
Neurosurgery. 58(4 Suppl 2):ONS-280 [PMID] 16582651.
2006
Faces of emotion in Parkinsons disease: micro-expressivity and bradykinesia during voluntary facial expressions.
Journal of the International Neuropsychological Society : JINS. 12(6):765-73 [PMID] 17064440.
2006
Genome-wide genotyping in Parkinson’s disease and neurologically normal controls: first stage analysis and public release of data.
The Lancet. Neurology. 5(11):911-6 [PMID] 17052657.
2006
Hypersexuality and paraphilia induced by selegiline in Parkinson’s disease: report of 2 cases.
Parkinsonism & related disorders. 12(6):392-5 [PMID] 16730214.
2006
Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders.
CNS spectrums. 11(7):521-36 [PMID] 16816792.
2006
Long-term habituation of the smile response with deep brain stimulation.
Neurocase. 12(3):191-6 [PMID] 16801154.
2006
LRRK2 mutations in a clinic-based cohort of Parkinson’s disease.
European journal of neurology. 13(12):1298-301 [PMID] 17116211.
2006
Panic and fear induced by deep brain stimulation.
Journal of neurology, neurosurgery, and psychiatry. 77(3):410-2 [PMID] 16484657.
2006
Startling facts about emotion in Parkinson’s disease: blunted reactivity to aversive stimuli.
Brain : a journal of neurology. 129(Pt 12):3356-65 [PMID] 17095520.
2006
Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Archives of neurology. 63(5):729-35 [PMID] 16682542.
2006
The human prion gene M129V polymorphism is not associated with idiopathic Parkinson’s disease in three distinct populations.
Neuroscience letters. 395(3):227-9 [PMID] 16298483.
2006
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 31(11):2384-93 [PMID] 16855529.
2006
Tutorial on maximum inspiratory and expiratory mouth pressures in individuals with idiopathic Parkinson disease (IPD) and the preliminary results of an expiratory muscle strength training program.
NeuroRehabilitation. 21(1):71-9 [PMID] 16720940.
2005
Bilateral sixth nerve paresis in the Bing-Neel syndrome.
Neurology. 64(3):576-7 [PMID] 15699407.
2005
Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia.
Movement disorders : official journal of the Movement Disorder Society. 20(4):500-501 [DOI] 10.1002/mds.20349. [PMID] 15593315.
2005
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.
Archives of neurology. 62(8):1250-5 [PMID] 15956104.
2005
Mild cognitive impairment in Parkinson’s disease: the challenge and the promise.
Neuropsychiatric disease and treatment. 1(1):37-50 [PMID] 18568128.
2005
Mood and cognitive changes with deep brain stimulation. What we know and where we should go.
Minerva medica. 96(3):125-44 [PMID] 16175157.
2005
Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder.
Movement disorders : official journal of the Movement Disorder Society. 20(11):1523-7 [PMID] 16037914.
2005
Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 20(1):104-5 [PMID] 15390047.
2005
Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease.
NeuroRehabilitation. 20(4):323-33 [PMID] 16403998.
2005
Staged deep brain stimulation for refractory craniofacial dystonia with blepharospasm: case report and physiology.
Neurosurgery. 56(2) [PMID] 15670394.
2005
Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor.
Archives of neurology. 62(1):141-3 [PMID] 15642861.
2005
Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return?
Archives of neurology. 62(4):533-6 [PMID] 15824249.
2005
Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note.
Neurosurgery. 56(2 Suppl) [PMID] 15794849.
2004
A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery.
The neurologist. 10(5) [PMID] 15335446.
2004
Alien limb syndrome and moya-moya disease.
Movement disorders : official journal of the Movement Disorder Society. 19(11):1317-20 [PMID] 15390006.
2004
Americo Negrette (1924 to 2003): diagnosing Huntington disease in Venezuela.
Neurology. 63(2):340-3 [PMID] 15277631.
2004
Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.
Archives of neurology. 61(12):1898-904 [PMID] 15596610.
2004
Aphasia and thalamotomy: important issues.
Stereotactic and functional neurosurgery. 82(4):186-90 [PMID] 15557767.
2004
Babinski’s clinical differentiation of organic paralysis from hysterical paralysis: effect on US neurology.
Archives of neurology. 61(5):778-83 [PMID] 15148160.
2004
Comparison of pallidal and subthalamic stimulation on force control in patient’s with Parkinson’s disease.
Motor control. 8(4):484-99 [PMID] 15585903.
2004
Development and initial validation of a screening tool for Parkinson disease surgical candidates.
Neurology. 63(1):161-3 [PMID] 15249630.
2004
Lesion therapy for Parkinson’s disease and other movement disorders: update and controversies.
Movement disorders : official journal of the Movement Disorder Society. 19(4):375-89 [PMID] 15077235.
2004
Magnetic resonance imaging of the posterior columns in vitamin B12 deficiency.
Archives of neurology. 61(8) [PMID] 15313854.
2004
Plasma testosterone levels in Alzheimer and Parkinson diseases.
Neurology. 62(3):411-3 [PMID] 14872022.
2004
Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus.
Journal of neurology, neurosurgery, and psychiatry. 75(6):921-3 [PMID] 15146017.
2004
Psychosis in Parkinson’s disease.
Journal of geriatric psychiatry and neurology. 17(3):127-36 [PMID] 15312276.
2004
SANDO: another presentation of mitochondrial disease.
American journal of ophthalmology. 137(5):951-3 [PMID] 15126171.
2004
What’s in a “smile?” Intra-operative observations of contralateral smiles induced by deep brain stimulation.
Neurocase. 10(4):271-9 [PMID] 15788264.
2003
Huntington’s disease: what we learned from the original essay.
The neurologist. 9(4):175-9 [PMID] 12864927.
2003
Mood changes with deep brain stimulation of STN and GPi: results of a pilot study.
Journal of neurology, neurosurgery, and psychiatry. 74(11):1584-6 [PMID] 14617726.
2003
Rationale for current therapies in Parkinson’s disease.
Expert opinion on pharmacotherapy. 4(10):1747-61 [PMID] 14521485.
2003
Transient manic behavior after pallidotomy.
Brain and cognition. 52(2):281-3 [PMID] 12821111.
2003
Visual-spatial ability in Parkinson’s disease.
Frontiers in bioscience : a journal and virtual library. 8:s992-7 [PMID] 12957858.
2002
Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease.
Archives of neurology. 59(11):1750-3 [PMID] 12433262.
2002
Corticosteroid treatment of mitochondrial encephalomyopathies.
The neurologist. 8(5):313-5 [PMID] 12803678.
2002
Depression associated with Parkinson’s disease: clinical features and treatment.
Neurology. 58(4 Suppl 1):S63-70 [PMID] 11909987.
2002
Immobilization dystonia.
Journal of the neurological sciences. 201(1-2):79-83 [PMID] 12163198.
2002
Origins of the sensory examination in neurology.
Seminars in neurology. 22(4):399-408 [PMID] 12539061.
2002
Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity.
Archives of neurology. 59(5):807-11 [PMID] 12020264.
2002
Understanding gustatory sweating. What have we learned from Lucja Frey and her predecessors?
Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 12(3):179-84 [PMID] 12269550.
2001
Bilateral third nerve palsy as the presenting sign of systemic sarcoidosis.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 36(7):416-9 [PMID] 11794393.
2001
GHB: an important pharmacologic and clinical update.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 4(2):167-75 [PMID] 11466174.
2001
Listeria spinal cord abscess responsive to trimethoprim-sulfamethoxazole monotherapy.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 28(4):354-6 [PMID] 11766781.
2000
Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy.
Pediatric neurology. 23(1):62-3 [PMID] 10963973.
2000
Early diagnostic magnetic resonance imaging in acute disseminated encephalomyelitis.
Southern medical journal. 93(8):793-6 [PMID] 10963511.
2000
Lung transplants and paradoxical cerebral emboli.
Transplantation. 70(12):1805-6 [PMID] 11152114.
2000
Neurology was there: 1929: the end of a roaring decade of neurology.
Archives of neurology. 57(9):1370-3 [PMID] 10987909.

Grants

Dec 2023 ACTIVE
ADVANCING THALAMIC NEUROSTIMULATION FOR SUPPRESING ESSENTIAL VOICE TREMOR
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Apr 2023 ACTIVE
CTOA Okun – Residuals
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Jul 2022 – Jun 2023
Directional Globus Pallidus Internus Local Field Potentials as Biomarkers for the Motor Symptoms of Inherited and Idiopathic Dystonia
Role: Other
Funding: DYSTONIA MEDICAL RES FOU
Jun 2022 – Jul 2023
Neurodegeneration and Neuronal Fluctuations in DLB and AD
Role: Other
Funding: NATL INST OF HLTH NIA
Sep 2021 ACTIVE
Defining Targets for Tic Detection and Suppression in Tourette Syndrome Deep Brain Stimulation
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Sep 2021 ACTIVE
Multi-Stakeholder Engagement for Interdisciplinary Telehealth in Lewy Body Dementia
Role: Other
Funding: NATL INST OF HLTH NIA
Jul 2021 – Jul 2021
Optogenetic Modulation of Mesocorticolimbic Brain Networks as a Treatment for Parkinsons Disease Cognitive Dysfunction
Role: Other
Funding: AMER ACAD OF NEUROLOGY
May 2021 ACTIVE
Cognitive and Affective Network Dysfunction and Neuromodulation in Aging and Synucleinopathy
Role: Other
Funding: NATL INST OF HLTH NIA
May 2021 – Oct 2023
Balance and Gait in Essential Tremor: Effects of Thalamic DBS
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Apr 2021 ACTIVE
Web-based Automated Imaging Differentiation of Parkinsonism
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Sep 2020 – Aug 2021
Pediatric Deep Brain Stimulation: Neuroethics and Decision Making
Role: Principal Investigator
Funding: BAYLOR COLLEGE OF MEDICINE via NATL INST OF HLTH NIMH
Aug 2020 ACTIVE
Interdisciplinary Training in Movement Disorders and Neurorestoration
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
May 2020 – Aug 2021
Wearable-Sensor Driven Responsive Deep Brain Stimulation for the Improved Treatment of Essential Tremor
Role: Other
Funding: NATL INST OF HLTH NINDS
Jan 2020 – Jun 2022
Application of Free-water Imaging & a Transcallosal Tractography Template in DLB: A Novel Biomarker
Role: Other
Funding: UF FOUNDATION
Dec 2019 ACTIVE
LRRK2-Synuclein Interactions with Gut Inflammation in PD Pathogenesis
Role: Co-Investigator
Funding: PARKINSONS FOU
Oct 2019 ACTIVE
Registry of Deep Brain Stimulation with the VERCISE System: Vercise DBS Registry
Role: Principal Investigator
Funding: BOSTON SCIENTIFIC CORP
Sep 2019 ACTIVE
Dual Lead Thalamic DBR-DBS Interface for Closed Loop Control of Severe Essential Tremor
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Sep 2019 – Aug 2022
Adoptive Cell Therapies and Translational Neuroimaging in Synucleinopathy: Implications for Dementia with Lewy Body and Parkinson's Disease
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Aug 2019 – Apr 2020
Gait as a biomarker for clinicians and researchers in Parkinsons disease
Role: Project Manager
Funding: TEL AVIV SOURASKY MEDICAL CENTER via FOX FOU, MICHAEL J
Jul 2019 ACTIVE
University of Florida R25 Early Research Program for Neurology and Neurosurgery Residents
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Jun 2019 – Dec 2023
Improving Access to Deep Brain Stimulation Therapy
Role: Principal Investigator
Funding: TOURETTE ASSOCIATION OF AMERICA
May 2019 – May 2022
Local field potentials reveal reward processing and impulse control disorders in Parkinsons disease
Role: Other
Funding: NATL INST OF HLTH NINDS
Mar 2019 – Mar 2022
Ataxia Research Fund: Support for Ataxia research and education
Role: Project Manager
Funding: UF FOUNDATION
Jul 2018 – Jun 2020
Physiologic Approach to Human Tics Tic Detector
Role: Other
Funding: AMER ACAD OF NEUROLOGY
Apr 2018 – Jan 2020
CODY: Assistive Technology for SAH Assessments
Role: Co-Project Director/Principal Investigator
Funding: US DEPT OF VETERANS AFFAIRS
Apr 2018 ACTIVE
Supraspinal Control of Human Locomotor Adaptation
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Oct 2017 – Sep 2023
Automated Analysis of Movement Disorders from Diffusion and Functional MRI
Role: Co-Project Director/Principal Investigator
Funding: NATL SCIENCE FOU
Sep 2017 – Aug 2022
Neuroethics of aDBS Systems Targeting Neuropsychiatric and Movement Disorders
Role: Principal Investigator
Funding: BAYLOR COLLEGE OF MEDICINE via NATL INST OF HLTH NIMH
Sep 2017 – Jul 2021
New Statistical and Computing Technologies for Bereaking the Barrier to Medical Data Sharing
Role: Co-Investigator
Funding: NATL INST OF HLTH NIGMS
Sep 2017 – Jun 2021
Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease Progression
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Aug 2017 – May 2023
Mechanisms of airway protection dysfunction in Parkinson's disease
Role: Co-Investigator
Funding: NATL INST OF HLTH NICHD
Sep 2016 ACTIVE
Closing the Loop on Tremor: A Responsive Deep Brain Stimulator for the Treatment of Essential Tremor
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Aug 2016 – May 2023
Scaling and Sequencing Motor Output in Humans: fMRI Study
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Jul 2016 – Jun 2023
The Human Thalamocortical Network in tourette syndrome
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Jul 2016 – Jun 2020
Novel Management of Airway Protection in Parkinson's disease: A clinical trial
Role: Co-Investigator
Funding: COLUMBIA UNIVERSITY via FOX FOU, MICHAEL J
Jul 2015 – Jun 2016
Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia
Role: Principal Investigator
Funding: DYSTONIA MEDICAL RES FOU
Apr 2015 – Jan 2018
A Prospective, Randomized, Cross-Over, Feasibility Study of TOPS DBS for the treatment of Parkinson's Disease
Role: Principal Investigator
Funding: DEEP BRAIN INNOVATIONS LLC
Apr 2015 – Mar 2018
Airway protection deficits according to stimulus type in PD
Role: Project Manager
Funding: NATL INST OF HLTH NIDCD
Feb 2015 – Jan 2021
Mobile Decision Support System for Nurse Management of Neuromodulation Therapy
Role: Principal Investigator
Funding: UNIV OF UTAH via NATL INST OF HLTH NINR
Jan 2015 – Jul 2017
A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinsons Disease
Role: Principal Investigator
Funding: FOX FOU, MICHAEL J
Jan 2015 – Dec 2017
A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinsons Disease
Role: Principal Investigator
Funding: UF FOUNDATION
Aug 2014 – Jul 2017
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6124 or Placebo in Subjects with Mild to Moderate Alzheimers Disease
Role: Principal Investigator
Funding: INVENTIV HEALTH CLINICAL LLC via FORUM PHARMACEUTICALS
Mar 2014 – Dec 2017
Direct Functional Imaging of Electrical Brain Stimulation
Role: Project Manager
Funding: ARIZONA STATE UNIVERSITY via NATL INST OF HLTH NINDS
Sep 2013 – Nov 2022
Implantable Neurostimulator for the Treatment of Parkinson's Disease.
Role: Principal Investigator
Funding: BOSTON SCIENTIFIC CORP
Sep 2013 – Aug 2019
White Matter Connectivity and PD Cognitive Phenotypes
Role: Project Manager
Funding: NATL INST OF HLTH NINDS
Jul 2013 – Dec 2020
The Bachmann-Strauss Dystonia & Parkinson's Disease Center of Excellence at theUniversity of Florida-Tyler's Hope Matching
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2013 – Jul 2016
The Bachmann-Strauss Dystonia & Parkinson's Disease Center of Excellence at theUniversity of Florida
Role: Principal Investigator
Funding: BACHMANN-STRAUSS DYSTONIA & PARKINSON FO
Nov 2012 – Jun 2019
TSA INTERNATIONAL DATABASE OF DEEP BRAIN STIMULATION STUDIES IN TOURETTE SYNDROME
Role: Principal Investigator
Funding: TOURETTE ASSOCIATION OF AMERICA
Oct 2012 – Apr 2017
Dance for Life: Assessing the Effects of Dance on Motor and Non-Motor Function in Parkinson's Disease
Role: Project Manager
Funding: PARKINSONS FOU
Sep 2012 – Sep 2018
Non-invasive markers of Neurodegeneration in Movement Disorders
Role: Project Manager
Funding: NATL INST OF HLTH NINDS
Aug 2012 – Nov 2017
ADvance: A 12-month double-blind, randomized, controlled feasibility study to evaluate the safety, efficacy and tolerability of deep brain stimulation of the fornix (DBS-f) in patients with mild probable Alzheimers disease
Role: Principal Investigator
Funding: FUNCTIONAL NEUROMODULATION
Nov 2011 – Jul 2016
Scaling and Sequencing Motor Output in Humans: fMRI Study
Role: Project Manager
Funding: NATL INST OF HLTH NINDS
Jul 2011 – Sep 2019
Brain Bank for subjects implanted with the Libra Deep Brain Stimulation System
Role: Principal Investigator
Funding: ST JUDE MEDICAL CENTER
Nov 2010 – Dec 2016
Ampicillin for DYT-1 Dystonia: a Pilot Trial for Safety and Efficacy
Role: Principal Investigator
Funding: TYLER'S HOPE FOR A DYSTONIA CURE
Sep 2010 – Dec 2017
A Long-Term Follow Up Study of the Patients Who Underwent Unilateral or Bilateral Stimulation of the (VIM) Using the Libra Deep Brain Stimulation System for the Suppression of Tremor in the Upper Extremities of Patients with Essential Tremor
Role: Principal Investigator
Funding: ADVANCED NEUROMODULATION SYSTEMS
Mar 2010 – Mar 2016
Quantifying Deficits in Patients with Movement Disorders Program
Role: Principal Investigator
Funding: UF FOUNDATION
Jul 2007 – Aug 2016
Clinical and Translational Science Institute
Role: Project Manager
Funding: UF RESEARCH FOU
Jul 2006 ACTIVE
BRAIN AND SPINAL CORD INJURY RESEARCH
Role: Project Manager
Funding: FL DEPT OF HLTH
Aug 2005 – Jul 2020
Ask The Doctor Forum with National Parkinson Foundation
Role: Principal Investigator
Funding: PARKINSONS FOU

Education

Fellow in Movement Disorders and Stereotactic Surgery for Movement Disorders
2000-2002 · Emory University
Residency – Neurology
2000 · University of Florida
Residency – Internal Medicine
1997 · University of Florida
Medical Degree
1996 · University of Florida

Contact Details

Phones:
Business:
(352) 294-5400
Emails:
QPSi – Administrative Specialist III:
Addresses:
Business Mailing:
PO Box 100268
GAINESVILLE FL 32610
Business Street:
3011 SW WILLISTON RD RM 1103
GAINESVILLE FL 32608